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TISSUE SPECIFICITY OF SEX-BIASED GENE EXPRESSION AND THE DEVELOPMENT 
OF SEXUAL DIMORPHISM  
by 
ALBERT K. CHUNG 
(Under the Direction of Christian L. Cox) 
ABSTRACT  
One prominent form of phenotypic diversity in nature is the dramatic difference between 
males and females within a single species. A central genetic obstacle which must be overcome is 
that two distinct phenotypes must be produced from a single, shared genome. One genetic 
mechanism that is of particular import that would allow sexes to overcome the limitation of a 
shared genome is sex-specific regulation of gene expression. Although sex-biased gene 
expression is generally predicted to increase over ontogeny as male and female phenotypes 
diverge, this pattern should be most pronounced in tissues that contribute to the most extreme 
aspects of sexual dimorphism. However, few studies have simultaneously examined multiple 
tissues throughout development to quantify sex-biased gene expression, which is crucial as 
sexual dimorphism occurs as a complex developmental process and sex-biased gene expression 
changes over time and differs among various tissues. We used the brown anole (Anolis sagrei), a 
lizard that exhibits extreme sexual size dimorphism, to examine sex-, age-, and tissue-specificity 
of gene expression. Using high-throughput RNA-Seq, we analyzed liver, muscle, and brain 
transcriptomes at one, four, eight, and twelve months of age. We predicted that (1) sex-biased 
gene expression would increase during ontogeny as phenotypes diverge between the sexes, (2) 
ontogenetic increases in sex-biased expression would differ among tissues because of different 
  
 
 
contributions to sexual dimorphism, and (3) growth-regulatory gene networks would be more 
sex-biased in liver and muscle than the brain as key contributors to extreme size dimorphism. We 
also predicted that sex-biased expression of upstream components of growth regulatory (e.g., 
hormones) networks in the liver would be higher compared to the muscle where there would be 
higher sex-biased expression of downstream components (e.g., hormone receptors and 
downstream effectors) in muscle. We determined that sex-biased gene expression increased 
during development, but that the trajectory of sex-biased expression varied between tissues. The 
liver had the greatest number of sex-biased growth genes, but the muscle had the greatest 
divergence of growth gene expression. We also found that while sex-biased expression of growth 
genes increased sharply during development in the liver and muscle, the brain showed no sex-
bias in any growth gene at any point. Our results confirm that sex-biased gene expression 
increases throughout ontogeny, but also demonstrate tissue-specific trajectories. Our results also 
suggest that different components of growth-regulatory networks are activated in different 
tissues. More broadly, our work implies that sex-biased gene expression across the whole 
transcriptome and within specific regulatory pathways produces sexually dimorphic phenotypes.  
 
INDEX WORDS: Sexual dimorphism, Ontogeny, Anolis, Differential gene expression, RNA-
Seq, Transcriptomics  
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GENERAL INTRODUCTION 
Sexual Dimorphism 
 Sexual dimorphism, which is the physiological or behavioral differences between the 
sexes of one species, is one of the most conspicuous sources of phenotypic diversity in nature. 
From the brightly colored plumage of the peacock to paternal care of offspring in stickleback 
fish, sexual dimorphism is ubiquitous among animals and has long been studied by evolutionary 
biologists who seek to understand its evolution (Darwin 1888). There are three main hypotheses 
that explain the evolution of sexual dimorphism (Hedrick & Temeles 1989): ecological 
divergence between the sexes (Selander 1966; Shine 1989), natural selection (Darwin 1888), and 
sexual selection (Darwin 1888). 
 Ecological hypotheses regarding the evolution of sexual dimorphism posit that ecological 
factors drive the evolution of sexual dimorphism (Selander 1966; Shine 1989). Under an 
ecological causation model (Shine 1989), male and female competition (i.e., intersexual 
competition) for ecological resources (e.g., prey items) leads to disruptive selection (i.e., sexual 
dimorphism) and evolution of phenotypic characters such that the sexes occupy separate 
ecological niches (i.e., ecological niche partitioning). Ecological niche partitioning between the 
sexes has been observed across several lineages of snakes (Mushinsky, Hebrard & Vodopich 
1982; Shine 1991b; Shine 1991a; Houston & Shine 1993; Shetty & Shine 2002; Shine et al. 
2002) where species have developed sexual size dimorphism and consume different sized prey 
items. 
 Natural selection is thought to drive the evolution of sexual dimorphism by acting 
differently on the sexes based on their differing reproductive roles (Darwin 1888) (i.e., fecundity 
advantage hypothesis). In sexually dimorphic species, natural selection is thought to act mainly 
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on females by selecting for larger body sizes. Under the fecundity advantage hypothesis, females 
with larger body sizes are more capable of allocating energy to reproduction, producing more 
and/or higher quality offspring, and are better able to provide resources to their offspring 
compared to females with smaller bodies. Larger female body size, therefore, provides a 
reproductive advantage and is selected for, driving the evolution of larger females and causing 
sexual size dimorphism. The fecundity advantage hypothesis has been used to explain the 
occurrence of female-biased sexual size dimorphism across a range of taxa including 
invertebrates (Bateman 1948; Head 1995), amphibians (Shine 1979), reptiles (Berry & Shine 
1980), birds (Summers & Underhill 1991; Sandercock 1998), and mammals (Ralls 1976). 
  Sexual selection promotes differential mating success, which can drive phenotypic 
divergence between the sexes (Darwin 1888). Sexual selection acts through two separate 
processes: intrasexual selection (e.g., male-male competition) and intersexual selection (e.g., 
female choice). Intrasexual selection occurs when differential mating success is determined by 
individuals of one sex competing with each other to mate with the other sex. This competition 
causes selection to act on the competing sex, often favoring the evolution of larger male body 
size and other traits that may confer an advantage when competing for mates (Darwin 1888; 
Andersson 1994). Thus, intrasexual selection drives phenotypic divergence between the sexes 
through selective pressures imposed by a sex on itself. 
 Intersexual selection, which commonly occurs as female choice although it may also 
occur as male choice, occurs when differential mating success is determined by the choice of 
females to mate with males that possess attractive phenotypic traits (Darwin 1888; Kirkpatrick 
1982; Andersson 1994; Fisher 1999). Female choice is able to drive sexual dimorphism as only 
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males with attractive traits will reproduce and these attractive traits are able to rapidly increase in 
frequency across generations causing male phenotypes to diverge from female phenotypes. 
Sexual Dimorphism and Differential Gene Expression 
 A central paradox of the development of sexual dimorphism is that a species must 
produce two distinct phenotypes from a single, shared genome (Lande 1980). Many sexually 
dimorphic species possess sex chromosomes, non-autosomal chromosomes that contain genes 
which determine sex and make it possible for one sex to possess genes that the other does not 
(Rice 1984; Mank 2009). However, the number of genes limited to sex chromosomes relative to 
genes on autosomal chromosomes is quite small and there are sexually dimorphic species that do 
not possess sex chromosomes at all (Bachtrog et al. 2014). This implies that the majority of 
sexually dimorphic traits result from shared genes. Male and female differential expression of 
shared genes, sex-biased gene expression, is one genetic mechanism that may allow sexual 
dimorphism to develop from a shared genome (Ellegren & Parsch 2007; Mank 2009; Williams & 
Carroll 2009; Mank et al. 2010; Grath & Parsch 2016; Mank 2017).  
Study System 
 Brown anoles (Anolis sagrei) are small lizards that are native to Cuba and The Bahamas 
and exhibit male-biased extreme sexual size dimorphism with males attaining more than double 
the body mass of females (Cox & Calsbeek 2010; Reedy et al. 2016). Brown anoles typically 
live for just one year and exhibit a territorial social structure with both sexes engaging in non-
monogamous mating (Schoener & Schoener 1980; Calsbeek et al. 2007). Anole species often fall 
into specific ecological niches referred to as ecomorphs, an ecomorph being, “species with the 
same structural habitat/niche, similar in morphology and behavior, but not necessarily close 
phyletically” (Williams 1972). Brown anoles belong to the trunk-ground Anolis ecomorph 
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(Losos 2011) and are often found on broad surfaces (e.g., tree trunks, walls) within two meters of 
the ground. Males and females experience different selective pressures which likely drive the 
evolution of sexual size dimorphism in this species. 
 In Anolis species, patterns of sexual size dimorphism are strongly tied to ecomorph class 
(Butler, Schoener & Losos 2000). The brown anole belongs to the trunk-ground ecomorph, 
which exhibits male-biased sexual size dimorphism, providing support for ecological forces 
driving the evolution of sexual size dimorphism in brown anoles. Body size is a critical factor 
that affects male combat outcomes in brown anoles (Tokarz 1985) and is likely subject to sexual 
selection as larger males are able to occupy higher quality territories (Schoener & Schoener 
1980) although the lack of a strict territorial polygynous social structure (Kamath & Losos 2017) 
may undercut the strength of sexual selection in brown anoles. Support for the fecundity 
advantage hypothesis is only weakly supported among reptiles (Cox, Butler & John-Alder 2007), 
although increases in clutch size are generally associated with increases in female-biased sexual 
size dimorphism in lizards (Cox, Skelly & John‐Alder 2003), thus natural selection for larger 
female body size might be a relatively weak driving force of sexual size dimorphism in brown 
anoles. We sought to understand how differential gene expression between the sexes within 
several tissues and across ontogeny facilitates the development of sexual dimorphism in an 
organism that is subject to these evolutionary pressures. 
 Previous work on sex-biased gene expression, which is expression of a gene that is 
exclusive to or at a higher level for one sex, has shown that large proportions of expressed genes 
exhibit sex-biased expression, in both adult gonadal and whole organism tissue preparations 
(Zhang et al. 2007; Mank et al. 2010), and have linked the magnitude of sex-bias in gene 
expression to the magnitude of sexual dimorphism (Pointer et al. 2013; Harrison et al. 2015). We 
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also know that sex-biased gene expression patterns change over ontogeny (Perry, Harrison & 
Mank 2014) and exhibit tissue-specificity (Yang et al. 2006). However, few, if any, studies have 
integrated these approaches to examine how sex-biased gene expression patterns of several 
tissues across ontogeny are linked to the development of sexual dimorphism. 
Experimental Design 
 We sought to examine the relationship between the amount of sex-biased expression, in 
both number of sex-biased genes and the degree to which a gene’s expression is biased towards 
one sex, and phenotypic dimorphism across tissues and over time. We collected liver, femoral 
muscle, and brain tissue from male and female brown anoles at ages one month, four months, 
eight months, and twelve months to examine age-, sex-, and tissue-specificity of sex-biased gene 
expression in the brown anole across ontogeny. We hypothesize that as phenotypic divergence 
increases between male and female brown anoles, sex-biased gene expression should as well as a 
general pattern across ontogeny to facilitate the development of sexual dimorphism from a single 
genome. Furthermore, we hypothesize that tissues should exhibit different patterns of sex-biased 
gene expression, both over time and from other tissues, as they contribute different amounts to 
sexual dimorphism at different developmental stages with tissues that contribute more to 
expression of phenotypic differences having higher levels of sex-biased gene expression. In 
addition, we hypothesize that signaling pathways that control the development of growth, and 
therefore sexual size dimorphism, exhibit sex-biased expression as well, specifically downstream 
elements that are the effectors of phenotypic divergence. In particular, we examined the 
expression of the growth hormone/insulin-like growth factor, insulin signaling, and mechanistic 
target of rapamycin growth regulatory gene networks. We utilized our experimental design, that 
sampled multiple tissues over an ontogenetic time-series from male and female brown anoles, to 
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perform differential gene expression analysis to test our hypotheses and answer these questions: 
(1) Does sex-biased gene expression increase during ontogeny as phenotypes diverge between 
the sexes? (2) Do ontogenetic increases in sex-biased expression differ among tissues that differ 
in function and therefore contribute different amounts to sexual dimorphism? (3) Are growth-
regulatory gene networks more sex-biased in liver and muscle than the brain as they are key 
contributors to extreme size dimorphism in brown anoles.  
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CHAPTER 1 
SEX-BIASED GENE EXPRESSION AND THE DEVELOPMENT OF SEXUAL SIZE 
DIMORPHISM 
ABSTRACT 
 Sexual dimorphism is a fundamental source of phenotypic diversity in nature, but the 
evolution of sexual dimorphism is expected to be constrained due to the sexes sharing a single 
genome. However, differential expression of shared genes between the sexes may be a genetic 
mechanism that allows species to develop sexual dimorphism despite the genomic constraint of 
shared genome. Because sexual dimorphism occurs as a developmental process, patterns of 
differential gene expression between the sexes should change over time and also differ within 
tissues that contribute differently to the development of sexual dimorphism. We performed an 
RNA-Seq experiment to examine the differential gene expression basis of sexual dimorphism 
and found that sex-, age-, and tissue-specific patterns of differential gene expression underlie the 
development of sexual dimorphism. 
INTRODUCTION 
 Sexual dimorphism is a fundamental source of phenotypic diversity in nature. Sexual 
dimorphism has long been of interest to evolutionary biologists, because it can affect many 
aspects of a species’ evolutionary trajectory, including physiology, behavior, and life history 
(Andersson 1994). Despite the importance of sexual dimorphism in evolutionary biology, we 
know relatively little about how the development of sexual dimorphism is regulated on the 
genetic level. 
 Sexual dimorphism presents a genomic paradox: two phenotypes are produced from a 
single genome. Even in species with genetic sex determination, where genes on sex 
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chromosomes direct the development of phenotypic divergence, only a few genes are truly sex-
limited (Koerich et al. 2008; Hughes et al. 2012; Moghadam et al. 2012) and the majority of 
genes responsible for sexual-dimorphic traits lie on autosomes (Mank 2009). Thus, male and 
female phenotypes must be produced from the shared autosomal genome. Resolving this 
apparent genetic paradox will allow us to understand how the sexes produce dimorphic 
phenotypes despite sharing a genome, giving us insight into the evolution and development of 
sexual dimorphism, a fundamental source of phenotypic variation and diversity in nature.  
 Due to the sexes sharing a largely, and often completely, identical genome, sexual 
dimorphism is expected to be produced from differential expression between the sexes (i.e., sex-
biased expression) of shared autosomal genes (Ellegren & Parsch 2007; Mank 2009; Williams & 
Carroll 2009; Mank et al. 2010; Grath & Parsch 2016; Mank 2017). As phenotype is ultimately 
determined by genotype, it is predicted that as phenotypic divergence between the sexes 
increases over ontogeny, there should be an accompanying divergence in gene expression 
between the sexes. However, because tissues differ in their contribution to phenotypic sexual 
dimorphism, gene expression patterns will not be uniform across tissues (Mank et al. 2008). 
Thus, not only should there be differing patterns of gene expression during ontogeny within each 
sex, but there must be also tissue-specific patterns of sex-biased gene expression that change 
during ontogeny. 
 With the advent of high-throughput sequencing, several studies examining gene 
expression patterns between the sexes have been published in recent years. Some studies of 
sexual dimorphism have characterized gene expression patterns of multiple tissues at a single 
time point (Mank et al. 2008; Pointer et al. 2013; Stuglik et al. 2014). Other studies have 
characterized gene expression profiles at multiple time points using single-tissue or whole-body 
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RNA preparations (Mank et al. 2010; Perry, Harrison & Mank 2014; Shi, Zhang & Su 2016; Cox 
et al. 2017). Few studies have examined gene expression patterns of multiple tissues that 
contribute to sexual dimorphism at multiple age points. 
 We studied the ontogeny of sex-biased gene expression patterns in several tissues that 
contribute to sexual dimorphism in the brown anole, Anolis sagrei. This sexually dimorphic 
lizard exhibits male-biased extreme sexual size dimorphism, with males exceeding two to three 
times the mass of females (Cox & Calsbeek 2010; Reedy et al. 2016). We performed an RNA-
Seq experiment and constructed whole transcriptomes for the liver, muscle, and brain tissues of 
males and females at one, four, eight, and twelve months of age. We chose these ages to sample 
changing gene expression patterns as males and females develop from monomorphic phenotypes 
at one month to full dimorphism at twelve months. We focused on liver because it regulates 
metabolism and growth and is, therefore, important to the development of size dimorphism. 
Muscle is a dimorphic tissue, being larger in males than in females, and is a component in the 
extreme sexual size dimorphism of anoles with males possessing larger muscles. The brain is not 
dimorphic in size between the sexes so it can act as a control for growth gene activity and it 
serves an important role functionally as an integral component in the endocrine system that 
regulates growth. We conducted differential gene expression analyses to examine sex-biased 
gene expression patterns within each tissue and sex across the brown anole’s ontogeny. 
 We predicted that as the sexes increase in phenotypical divergence, gene expression 
divergence in both number of genes with sex-biased expression and amount of expression of 
those sex-biased genes would increase over ontogeny and across tissues. We predicted that 
tissue-specific patterns in both numbers of sex-biased genes and levels of sex-biased gene 
expression would differ from each other. In the brain, we predicted low numbers of sex-biased 
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genes and low levels of sex-biased gene expression with little divergence between the sexes in 
both number of sex-biased genes and level of expression of sex-biased genes, relative to the 
other tissues, across ontogeny as it is an upstream regulator of growth and is not a target tissue 
for growth regulatory signals. In the liver, which exhibits expression of both upstream and 
downstream growth regulators and signaling targets, we predicted higher numbers of genes with 
male-biased expression (i.e., male-biased genes), relative to genes with female-biased expression 
(i.e., female-biased genes), and higher expression of male-biased genes relative to female-biased 
genes. We also expected, in the liver, that gene expression would show increasing sexual 
divergence as the sexes diverge in size over time. In muscle, we had the same predictions as in 
the liver, however, we expected that sex-biased gene expression would be lower in both number 
of sex-biased genes and amount of sex-biased expression relative to the liver as muscle is a 
downstream target of signaling pathways that regulate growth. We found that tissues vary in the 
extent and magnitude of sex-biased gene expression over time, implying that complex regulation 
of gene expression throughout ontogeny orchestrates the development of sexual size 
dimorphism. 
MATERIALS AND METHODS 
Study System 
 The brown anole is a small lizard native to Cuba and The Bahamas that exhibits male-
biased extreme sexual size dimorphism. As hatchlings and juveniles, male and female brown 
anoles are sexually monomorphic, often distinguishable only by back pattern and size of post-
anal scales. Throughout their ontogeny, anoles diverge in size until reaching sexual maturity at 
one year of age, when males are much larger, up to two to three times the mass of females, and 
possess a brightly colored dewlap. The animals used in this study were descendants of wild adult 
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Anolis sagrei lizards collected in January 2012 from the island of Great Exuma, near George 
Town, in The Bahamas. These lizards were transported to a breeding facility at the University of 
Virginia and were bred in a common garden design for several generations. 
Animal husbandry 
 The animals used in this study hatched from June 2015 to January 2017. Animals were 
housed individually in plastic cages (30  20  20 cm; Lee’s Kritter Keeper, San Marcos, 
California, U.S.A.) with a carpet substrate, a strip of fiberglass screening for basking, and a piece 
of PVC pipe (2.5 cm diameter, 30 cm length) for hiding in and perching on. Animals were 
maintained at constant humidity (65%), temperature (29°C diurnal, 25°C nocturnal), and 
photoperiod (13L:11D during spring, summer, and fall; 12L:12D during winter) and cages were 
placed underneath two ReptiSun 10.0 UVB bulbs (ZooMed; San Luis Obispo, California, 
U.S.A.). Cage walls and potted plants were sprayed with deionized water twice per day. Three 
times per week, juvenile and adult animals were fed crickets (Gryllus assimilis and Gryllus 
sigillatus; Ghann’s Cricket Farm, Augusta, Georgia, U.S.A.); juveniles were fed 10–15 1/4-inch 
crickets, adult females were fed three to five 3/8-inch crickets, and adult males were fed five to 
seven 1/2-inch crickets. Hatchling animals were fed 10–15 pinhead crickets (Acheta domestica) 
daily. Crickets were dusted weekly with Fluker’s Reptile Vitamin and Calcium Supplements 
(Fluker’s Cricket Farms; Port Allen, Louisiana, U.S.A.). 
Tissue Collection 
 Liver, muscle, and brain tissue were collected from lizards of one, four, eight, and twelve 
months of age. Tissues from age groups four, eight, and twelve months were collected between 
May 19 and June 10, 2016; one-month tissues were collected in February 2017. All tissues were 
collected from 10:00-14:00 (EST) to avoid potential circadian rhythm confounding factors. For 
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ages four, eight, and twelve months, tissues were collected from five males and five females, 
selected to minimize deviation from mean mass within each sex and age group; for age one 
month, tissues were collected from four males and four females as that was the maximum equal 
number of individuals per sex available. Immediately prior to tissue collection, individuals were 
euthanized by decapitation, approved by the University of Virginia Animal Care and Use 
Committee (Protocol 3896), and then immediately dissected. The entire liver, femoral muscle, 
and whole brain were collected and immediately placed in 2 mL screw cap centrifuge tubes filled 
with RNAlater™ RNA Stabilization Solution (Thermo Fisher Scientific; Waltham, 
Massachusetts, U.S.A.) to prevent RNA degradation. Tissue samples were then stored at 4°C 
overnight to allow the solution to thoroughly penetrate the tissue, as suggested by the manual, 
before being stored at -80°C until RNA was isolated. 
RNA Isolation and Sequencing 
 Tissues were thawed, removed from RNAlater solution, and placed into new RNAse-free 
centrifuge tubes filled with 1 mL of TRIzol reagent (Invitrogen; Waltham, Massachusetts, 
U.S.A.) per 100 mg of tissue and four 2.4 mm stainless steel beads. Tissues were then lysed 
using a TissueLyser II (Qiagen; Hilden, Germany) at 20 Hz for 12 minutes, with the tubes 
rotated at six minutes, and incubated at room temperature for five minutes following lysing. One 
hundred µL of 1-Bromo-3-chloropropane were then added to each tube, tubes were vortexed for 
15 seconds, allowed to incubate at room temperature for five minutes, and then centrifuged at 
12,000 g for five minutes to extract RNA from lysed tissues. The RNA-containing upper aqueous 
phase of each tube was then transferred to a fresh tube and 500 µL of isopropanol was added 
before storing at –80° C overnight to precipitate isolated RNA from solution. Tubes were then 
incubated at room temperature for 5 minutes and centrifuged at 12,000 g for eight minutes to 
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produce an RNA pellet before discarding the supernatant. One mL of 75% ethanol, prepared with 
nuclease-free water, was then added, tubes were gently mixed, and then allowed to sit for 30 
seconds before centrifuging at 12,000 g for five minutes and discarding supernatant. The isolated 
RNA was then allowed to air-dry for 30 minutes, centrifuged at 12,000 g for four minutes, and 
any remaining ethanol was discarded. RNA was then re-suspended in 50 µl of nuclease-free 
water. Quality and concentration of each RNA sample was evaluated using a Qubit Fluorometer 
(Qubit 2.0; Invitrogen; Waltham, MA) and an Agilent 2100 Bioanalyzer (Agilent Technologies, 
Inc.; Waldbronn, Germany). 
 The RNA samples of the one-month age group were pooled to meet minimum RNA 
concentration requirements for sequencing such that there was only one replicate per tissue per 
sex in contrast with the other three age groups, which had five replicates per tissue per sex. Thus, 
individual effects could not be examined within the one-month age class. 
 RNA samples were submitted to the Georgia Genomics Facility at the University of 
Georgia where cDNA libraries were assembled using Kapa Biosystems RNA library preparation 
(Kapa Biosystems; Boston, Massachusetts, U.S.A.) and sequenced on the Illumina NextSeq 500 
platform (Illumina; San Diego, California, U.S.A.) using two High-Output flow cells to generate 
paired end transcripts of 150 base pair length. 
Transcriptome Assembly and RNA-Seq Analysis 
 We mapped RNA-Seq data to the Anolis carolinensis genome (AnoCar2.0 assembly; 
Accessed September 4, 2018). RNA data was trimmed for Illumina adapter sequences and 
quality filtered using Trimmomatic version 0.36 (Bolger, Lohse & Usadel 2014). Our settings for 
Trimmomatic were to remove leading and trailing low quality bases below Phred33 quality of 
10, scan reads with a 4-base wide sliding window that cut when the average quality per base 
25 
 
 
 
dropped below Phred33 15, and drop reads that were less than 36 bases long. We discarded 
unpaired reads and aligned RNA data to the Anolis carolinensis genome using BWA version 
0.7.13 (Bolger, Lohse & Usadel 2014) using the MEM algorithm. Samtools version 1.8 (Li et al. 
2009) was used to convert file formats, sort alignments, index sorted files for fast random access, 
merge files belonging to the same sample, and output gene names and mapped transcript count 
for each sample. Gene expression was normalized across all samples using the trimmed mean of 
M-values normalization method (Robinson & Oshlack 2010) within edgeR (Robinson, McCarthy 
& Smyth 2010). EdgeR was then used to perform differential gene expression analysis between 
the sexes within each tissue and each age group, using a false discovery rate (Benjamini & 
Hochberg 1995) of 0.05. 
Statistical Methods 
 We performed linear regressions of pairwise comparisons between the sexes, using 
normalized gene expression values, within liver, muscle, and brain of their log2 fold changes of 
all genes that exhibit sex-biased expression, in any tissue and any age, across ontogeny. We 
performed 12 regressions and used a Bonferroni adjusted alpha level of 0.0042 to assess whether 
genes with sex-biased expression exhibited the same pattern of sex-biased expression across all 
tissues. In addition, we estimated linear regressions between adjacent ages of the log2 fold 
changes of all genes that exhibit sex-biased expression, in any tissue and any age, within the 
liver, muscle, and brain. We performed nine regressions and used a Bonferroni adjusted alpha 
level of 0.0056 to assess whether genes with sex-biased expression exhibit the same pattern of 
sex-biased expression across ontogeny within tissues. In addition, we used general linear models 
to test for differences in expression of all genes with sex-biased expression between sexes, ages, 
and tissues. 
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RESULTS 
Number of Genes Exhibiting Sex-biased Expression 
 Transcriptome assembly and differential gene expression analysis resulted in detection of 
expression of a total of 19,214 genes and 5,051 sex-biased genes across all tissues and ages with 
an average proportion of 61.5% mapped to unmapped reads across all samples. The number of 
genes with sex-biased expression generally increased over time for both sexes within each tissue 
mirroring the increase in body size that both sexes exhibit over ontogeny (Figure 1.1). The liver, 
muscle, and brain had divergent patterns in both numbers of genes with sex-biased expression 
and which sex had more sex-biased genes (Figure 1.2; Table 1.1). In general, we found more 
genes with female-biased expression than male-biased across all tissues and most age points, 
however the number of genes with sex-biased expression did not simply increase across all age 
points within each tissue. For all tissues, we found that there were much fewer sex-biased genes 
for the one-month age group compared to other ages in the one replicate for the one-month age 
group for each sex. 
 In the liver (Figure 1.2A), females had the greater number of genes with sex-biased 
expression across all age points. While the number of genes with male-biased expression 
continued to increase across all age points, the number of genes with female-biased expression 
only increased from one to eight months and slightly decreased from eight to twelve months. The 
greatest increase in number of sex-biased genes occurred between four months and eight months 
for both sexes. In the muscle (Figure 1.2B), females had the greater number of genes with 
sex-biased expression at all age points except at four months. While the number of genes with 
female-biased expression continuously increased across ontogeny, the number of male-biased 
genes only increased between one and four months and between eight and twelve months, 
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slightly decreasing between four and eight months in an almost sigmoidal fashion. The greatest 
increase in number of genes with sex-biased expression occurred between one month and four 
months for males and between eight months and twelve months in females. In the brain (Figure 
1.2C), the number of genes with female-biased expression continuously increased across all ages 
while the number of genes with male-biased expression increased from one to eight months 
before decreasing between eight and twelve months, which is the most decrease in the data. The 
numbers of genes with sex-biased expression were generally an order of magnitude less in the 
brain than in the liver and muscle (Table 1.1), reaching a maximum of 25 genes with male-biased 
expression and 13 genes with female-biased expression at any age compared to 614 male-biased 
and 1,013 female-biased genes in the liver and 622 male-biased and 1,139 female-biased genes 
in the muscle (see also Figure 1.2). 
Magnitude of Gene Expression 
 The mean expression of all genes was much higher in the liver and muscle than in the 
brain (Figure 1.3). The liver (Figure 1.3A) had a slight increasing trend in mean gene expression 
for both sexes over ontogeny which were approximately equal to each other. However, the 
muscle (Figure 1.3B) and brain (Figure 1.3C) both exhibited more constant mean levels of 
expression across ontogeny that was equal between the sexes. 
 The mean expression of all genes with sex-biased expression within each tissue was 
much higher in the liver than in the muscle or brain (Figure 1.4). In the liver (Figure 1.4A), both 
sexes slightly increased in mean expression of genes with sex-biased expression, however 
female-biased expression was much higher than male-biased expression in the latter thee ages 
compared to one month, but note that females have a parabolic relationship. In the muscle 
(Figure 1.4B), both sexes exhibited somewhat constant levels of mean expression of genes with 
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sex-biased expression over ontogeny relative to the liver, however mean male-biased expression 
was higher than mean female-biased expression at only one and four months. At eight and twelve 
months, mean female-biased gene expression was greater than mean male-biased expression. In 
the brain (Figure 1.4C), mean expression of genes with sex-biased expression was constant and 
approximately equal between the sexes over ontogeny. 
Overlap of Genes with Sex-Biased Expression Between Tissues Across Ontogeny 
 We performed pairwise comparisons of sex-biased genes between each tissue to 
determine the level of overlap of sex-biased genes between tissues across ontogeny (Table 1.2). 
Between the brain and either muscle or liver there were very few shared genes with sex-biased 
expression at any age. There was a maximum of 1.1% of genes with sex-biased expression at 
eight months exhibiting sex-biased expression in both the brain and muscle. The liver and 
muscle exhibited a similar pattern of non-overlap throughout ontogeny with the number of 
shared genes with sex-biased expression only reaching a maximum of 6.3% of total unique genes 
with sex-biased genes exhibiting sex-biased expression in both the liver and muscle at twelve 
months. These results indicate that the sexes exhibited sex-biased expression of different genes 
among tissues throughout ontogeny. 
Overlap of Sex-biased Genes Within Tissues Across Ontogeny 
 We performed pairwise comparisons between adjacent age points within each tissue to 
determine the level of overlap of genes with sex-biased expression within tissues across 
ontogeny (Table 1.3). Within the liver, the percentage of shared genes with sex-biased 
expression increased from 0.3% of total genes between one and four months exhibiting 
sex-biased expression at both ages to 23.1% of total genes between eight and twelve months 
exhibiting sex-biased expression at both ages. Within the muscle, the percentage of shared genes 
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with sex-biased expression did increase across ontogeny but only to a maximum of 8.1% of total 
genes with sex-biased expression between eight and twelve months exhibiting sex-biased 
expression at both ages. Within the brain, the percentage of shared genes with sex-biased 
expression between ages increased from 0% between one and four months to 23.1% between 
four and eight months but then decreased to 13.7% between eight months and twelve months. 
These results indicate that even within the same tissue, the genes that exhibit sex-biased 
expression did not remain constant. 
Relationship of Expression of Sex-biased Genes Between Tissues Across Ontogeny 
 We found significant positive correlations across all pairwise tissue comparisons and all 
ages except for in the one-month muscle and brain comparison (Figure 1.5). These results 
indicate that genes with sex-biased expression exhibited similar patterns of expression across 
tissues (e.g., if a gene with sex-biased expression gene exhibits female sex-biased gene 
expression in the liver, then the gene is likely to exhibit higher female expression than male 
expression in the muscle and brain as well). 
Relationship of Expression of Sex-biased Genes Between Ages Within Tissues 
 We found significant positive correlations across all age comparisons and tissues except 
for the one and four month muscle comparison (Figure 1.6). These results indicate that genes that 
exhibit sex-biased expression exhibited the same pattern of expression from age to age (e.g., if a 
gene exhibits male-biased expression at four months, then it is likely to exhibit higher male 
expression than female expression at one month and eight months as well within tissues). 
Sex-biased Gene Expression Levels 
 The expression levels of genes that exhibit sex-biased expression across the whole 
transcriptome only differed between tissues (Figure 1.3). Expression of sex-biased genes 
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significantly differed between the liver, muscle, and brain (F(2,484872) = 86.833, P < 0.0001). 
Expression of sex-biased genes did not differ between the sexes (F(1,484872) = 0.301, P = 0.58324) 
or between ages (F(3,484872) = 1.260, P = 0.28626). Furthermore, there were no significant 
interactions (all p-values > 0.05). Full results are available in Table 1.4. 
DISCUSSION 
 The relationship between sexual dimorphism and sex-biased gene expression has 
historically been unclear considering that not all genetic loci contribute equally or even show a 
direct impact on phenotype. Sexual dimorphism occurs as a developmental process (Mackay, 
Stone & Ayroles 2009; Emlen et al. 2012; Khila, Abouheif & Rowe 2012; Sanger et al. 2013), 
indicating the importance of ontogenetic patterns of sex-biased gene expression. In addition, rate 
of gene expression evolution varies among tissues (Brawand et al. 2011), indicating the 
importance of tissue-specific patterns of sex-biased gene expression. Indeed, sex-biased gene 
expression changes across ontogeny (Mank et al. 2010; Perry, Harrison & Mank 2014) and 
differs among tissues (Yang et al. 2006). Thus, to understand the complex relationship between 
sexual dimorphism and sex-biased gene expression, sex-biased gene expression must be 
examined across tissues and ontogeny. We determined that as brown anoles phenotypically 
diverge in size from monomorphic juveniles to sexually dimorphic adults (Figure 1.1), gene 
expression between the sexes diverged as well. As predicted, the number of male and female 
sex-biased genes increased over time (Figure 1.2; Table 1.1) in all tissues, mirroring the 
phenotypic divergence of the sexes. However, the changes in magnitude of gene expression 
between the sexes over time did not show clear patterns that correlate to phenotypic divergence.  
 In the liver and muscle, the number of sex-biased genes was two to three orders of 
magnitude greater than in the brain for both male-biased and female-biased genes in the four, 
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eight, and twelve month age groups. Although the brain is an important component of the 
endocrine system which regulates sexual development, sexual dimorphism may not require as 
many differentially expressed genes in the brain to develop compared to liver and muscle. The 
brain is an upstream component of the endocrine system, meaning that fewer numbers of 
sex-biased genes may be required in the brain to have large downstream effects that direct the 
development of sexual dimorphism. For example, expression of the two primary sex hormones, 
testosterone and oestrogen, which are regulators of sexual differentiation and sexual dimorphism 
(Owens & Short 1995; Lange, Hartel & Meyer 2002; Hau 2007; Cox, Stenquist & Calsbeek 
2009), are both regulated by gonadotropin-releasing hormone, follicle-stimulating hormone, and 
luteinizing hormone (Schally et al. 1971; Pierce & Parsons 1981), which are both expressed and 
released by the brain. However, it is important to note that due to the difficulty of extracting 
brain tissue, it is quite possible that regions from the base of the brain were not collected and this 
might be why we did not detect as many sex-biased genes in the brain. These results, in 
conjunction with the finding that magnitude of sex-biased gene expression does not differ with 
age among any tissues, indicate that differences in RNA abundance may not have a direct 
relationship to phenotypic dimorphism. 
 For females, our results suggest that there are biological processes in the liver that occur 
during development that do not continue into sexual maturity. In the liver (Figure 1.2A; Table 
1.1), the number of genes with female-biased expression peaked at eight months but in twelve 
months for genes with males-biased expression, although the increase in genes with male-biased 
expression from eight to twelve months is less than 25% of the increase from four months to 
eight months. These results may indicate that the liver’s contribution to the development of 
sexual dimorphism is greatest around eight months of age, when brown anoles are between 
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juvenile and adult phenotypes for both sexes. Given that the number of genes with female-biased 
expression decreased between eight and twelve months, despite still growing during that time 
frame, sex-biased gene expression may contribute the most to sexual dimorphism before the 
sexes reach maturity and are most phenotypically dimorphic. 
 The high number of genes with female-biased expression in muscle at twelve months 
may relate to changes in female behavior that includes increased foraging to support 
reproductive efforts, copulation, and oviposition. In the muscle, we found that the number of 
genes with female-biased expression steadily increased across all age groups to peak at 12 
months (Figure1.2B), but the number of genes with male-biased expression actually decreased 
between four and eight months, but then increased and peaked at twelve months. The number of 
genes with male-biased expression remained relatively constant from four to twelve months, 
peaking at 622 genes at twelve months, compared to increasing increases in the number of genes 
with female-biased expression that peaked at 1,139 at twelve months (Figure1.2B). These results 
might indicate that male muscle development is extended and begins earlier than female muscle 
development, corresponding to the development of the brown anole’s extreme sexual size 
dimorphism.  
 In the brain, there are fewer numbers of genes with sex-biased expression. Female brains 
peaked in the number of genes with sex-biased expression at 12 months while male brains 
peaked at 8 months (Figure 1.2C). This spike in genes with male-biased expression at eight 
months could correspond to how the greatest increase in phenotypic divergence between the 
sexes occurs between eight and twelve months of age. Between eight and twelve months, males 
not only attain doubled the mass of females (Figure 1.1). In contrast, females reached 
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approximate full size at eight months and may not require large changes in brain gene expression 
from eight to twelve months of age to support their development. 
 Tissues are distinct in their patterns of sex-biased gene expression, potentially revealing a 
physiological mechanism that allows for reduction of between-sex genetic correlations. Despite 
being closely linked by regulatory pathways and showing similar patterns of expression of genes 
with sex-biased expression both between tissues across ages (Figure 1.5) and between ages 
within tissues (Figure 1.6), we observed little to no overlap in sex-biased genes between tissues 
across ontogeny (Table 1.2). Even within tissues (Table 1.3), tissues largely exhibited sex-biased 
expression of different genes over time. In other words, tissue-specific patterns of gene 
expression were separate from each other and exhibit temporal trajectories that exhibit sex-
biased expression of largely different genes over time. Given this compartmentalization of 
sex-biased gene expression between tissues that changed temporally and how rates of sex-biased 
gene expression evolution differ among tissues (Brawand et al. 2011), tissue-specific sex-biased 
gene expression may be a mechanism that reduces the build-up of between-sex genetic 
correlations. Given that rates of gene expression within tissues are able to evolve separately from 
each other, perhaps tissue-specific gene expression patterns allow sexes to circumvent the 
obstacle of a shared genome by allowing tissues that contribute to different aspects of sexual 
dimorphism develop their own gene expression patterns separate from sex.  
 The evolutionary drivers of sexual dimorphism, and sexual size dimorphism in particular, 
are highly debated (Hedrick & Temeles 1989). Regardless of why sexual dimorphism evolves, 
sexes need to overcome the genetic obstacle of a shared genome that should make it difficult for 
the sexes to evolve independently (Lande 1980). Differential gene expression between the sexes 
is expected to allow species to overcome the genetic obstacle and evolve sexual dimorphism. We 
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found that phenotypic divergence between the sexes of the brown anole were accompanied by 
increases in sex-biased gene expression. However, this relationship is complex and there was no 
direct relationship between amount of sex-biased gene expression, in both number of genes with 
sex-biased expression and expression levels of those genes, across ages and tissues and amount 
of phenotypic dimorphism. In fact, sex-biased gene expression was highly age- and tissue-
specific with little overlap between ages and tissues and within tissues over time. This 
differential expression of genes between tissues and ages may provide the sexes the utility from a 
single genome to reduce between-sex genetic correlations by allowing the sexes to enact separate 
gene expression developmental programs that utilize different genes across tissues and ages to 
facilitate the development of sexual dimorphism. Furthermore, our results have broader 
implications for the evolution of phenotypic diversity. Because sexual dimorphism is essentially 
a form of polyphenism, conclusions from this study can be directly applied to other forms of 
intraspecific variation.  
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Table 1.1 The number of genes exhibiting sex-biased expression per sex at one, four, eight, and twelve months of age in liver, femoral 
muscle, and brain. 
Tissue Age (months) Female-biased genes Male-biased genes Total sex-biased genes 
Liver 1 6 1 7  
4 256 131 387  
8 1013 531 1544  
12 917 614 1531 
Muscle 1 9 3 12  
4 103 455 558  
8 459 436 895  
12 1139 622 1761 
Brain 1 0 0 0  
4 4 9 13  
8 25 10 35  
12 10 13 23 
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Table 1.2 Pairwise comparisons of overlap of genes exhibiting sex-biased expression between tissues at one, four, eight, and twelve 
months of age. 
Age 
(months) 
Pairwise Comparison of 
Tissues 
Total Number of Unique 
Sex-biased genes 
Number of Sex-biased Genes 
Unique to Tissue A (%) 
Number of Sex-biased Genes 
Unique to Tissue B (%) 
Number of Shared 
Sex-biased genes 
1 (A) Brain & (B) Muscle 12 0 (0%) 12 (100%) 0 (0%) 
4  566 8 (1.4%) 553 (97.7%) 5 (0.9%) 
8  920 25 (2.7%) 885 (96.2%) 10 (1.1%) 
12  1776 15 (0.8%) 1753 (98.7%) 8 (0.5%) 
1 (A) Muscle & (B) Liver 18 11 (61.1%) 6 (33.3%) 1 (5.6%) 
4  932 545 (58.5%) 374 (40.1%) 13 (1.4%) 
8  2326 782 (33.6%) 1431 (61.5%) 113 (4.9%) 
12  3096 1565 (50.5%) 1335 (43.1%) 196 (6.3%) 
1 (A) Liver & (B) Brain 7 7 (100%) 0 (0%) 0 (0%) 
4  396 383 (96.7%) 9 (2.3%) 4 (1.0%) 
8  1569 1534 (97.8%) 25 (1.6%) 10 (0.6%) 
12  1544 1521 (98.5%) 13 (0.8%) 10 (0.7%) 
 
  
41 
 
 
 
Table 1.3 Pairwise comparisons of overlap of genes exhibiting sex-biased expression between ages within the liver, femoral muscle, 
and brain. 
Tissue Pairwise Comparison of Ages Total Number of Unique 
Sex-biased genes 
Number of Sex-biased Genes 
Unique to Age A 
Number of Sex-biased Genes 
Unique to Age B 
Number of Shared 
Sex-biased genes 
Liver (A) 1 month & (B) 4 months 393 6 (1.5%) 386 (98.2%) 1 (0.3%) 
 (A) 4 Months & (B) 8 months 1733 189 (10.9%) 1346 (77.7%) 198 (11.4%) 
 (A) 8 months & (B) 12 months 2497 966 (38.7%) 953 (38.2%) 578 (23.1%) 
Muscle (A) 1 month & (B) 4 months 570 12 (2.1%) 558 (97.9%) 0 (0%) 
 (A) 4 Months & (B) 8 months 1354 459 (33.9%) 796 (58.8%) 99 (7.3%) 
 (A) 8 months & (B) 12 months 2458 697 (28.4%) 1563 (63.6%) 198 (8.1%) 
Brain (A) 1 month & (B) 4 months 13 0 (0%) 13 (100%) 0 (0%) 
 (A) 4 Months & (B) 8 months 39 4 (10.3%) 26 (66.7%) 9 (23.1%) 
 (A) 8 months & (B) 12 months 51 28 (54.9%) 16 (31.4%) 7 (13.7%) 
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Table 1.4 The results of a general linear model testing for sex, age, and tissue effects on  expression levels of all genes exhibiting sex-
biased expression. Factors with significant p-values are bolded. 
Factor Degrees of freedom F-value P-value 
Sex 1, 72 0.301019311 0.583244361 
Age 3, 72 1.259907315 0.286254905 
Tissue 2, 72 86.8325545 < 0.0001 
Sex:Age 3, 72 0.413555117 0.743268576 
Sex:Tissue 2, 72 0.601006427 0.548259983 
Age:Tissue 6, 72 1.827559699 0.089455459 
Sex:Age:Tissue 6, 72 0.511992897 0.799762388 
Residuals 72   
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Figure 1.1 As the sexes age, they increasingly diverge in size in both length and body mass. Data are the mean snout-vent length, in 
millimeters, and body mass, in grams, plotted against age of male and female brown anoles used in this RNA-Seq experiment. Data 
are expressed as means (symbols) with standard error bars (error bars shorter than the height of the symbol are not depicted).  
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Figure 1.2 The number of genes that exhibit sex-biased expression increases for both sexes and diverges between sexes within the 
liver, muscle, and brain across ontogeny. Data are numbers of genes that exhibit sex-biased expression, across all detected genes, 
plotted against age for male and female brown anoles in the liver, muscle, and brain. Note that the y-axis scale for the C) brain is much 
lower than for the A) liver and B) femoral muscle.  
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Figure 1.3 The sexes show similar mean expression of all genes to each other within tissues and across ontogeny. Data are the 
expression of all detected genes plotted against age for male and female brown anoles in the liver, muscle, and brain. Data are 
expressed as means (symbols) with standard error bars (error bars shorter than the height of the symbol are not depicted). 
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Figure 1.4 The sexes diverge in their expression levels of genes that exhibit sex-biased expression both between tissues and across 
ontogeny. Data are mean expression of genes with sex-biased expression plotted against age for male and female brown anoles in the 
liver, muscle, and brain. Data are expressed as means (symbols) with standard error bars (error bars shorter than the height of the 
symbol are not depicted). 
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Figure 1.5 Genes that exhibit sex-biased expression in one tissue exhibit the same direction of 
sex-bias in other tissues. Graphs are pairwise comparisons with linear regressions between 
tissues of the log2 fold changes of all genes that exhibited sex-biased expression, in any tissue 
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and any age, at each age. Both axes are in units of log2 fold change of the ratio of female to male 
gene expression. Positive log2 fold changes indicate greater female expression compared to male 
expression while negative log2 fold changes indicate greater male expression. Quadrant I 
contains genes that have exhibited sex-biased expression that have higher female expression than 
male expression in both tissues indicated by the axes. Quadrant II contains genes that have 
exhibited sex-biased expression that have higher female expression in the tissue on the y-axis 
and higher male expression in the tissue on the x-axis. Quadrant III contains genes that have 
exhibited sex-biased expression that have higher male expression in both tissues. Quadrant IV 
contains genes that have exhibited sex-biased expression with higher male expression in the y-
axis tissue and higher female expression in the x-axis tissue. Positive slopes of regression lines 
indicate that genes in one tissue with greater expression in one sex will have greater expression 
of the same sex in the other tissue. Note that all slopes, except for the comparison between 
muscle and brain at one month, are significant. 
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Figure 1.6 Genes that exhibit sex-biased expression at one age exhibit the same direction of sex-bias in adjacent ages within each 
tissue. Graphs are pairwise comparisons with linear regressions between adjacent ages of the log2 fold changes of all genes that have 
exhibited sex-biased expression, in any tissue and any age, within each tissue. Both axes are in units of log2 fold change of the ratio of 
female to male gene expression. Positive log2 fold changes indicate greater female expression compared to male expression while 
negative log2 fold changes indicate greater male expression. Quadrant I contains genes that have exhibited sex-biased expression that 
have higher female expression than male expression in both ages indicated by the axes. Quadrant II contains genes that have exhibited 
sex-biased expression that have higher female expression in the age on the y-axis and higher male expression in the age on the x-axis. 
Quadrant III contains genes that have exhibited sex-biased expression that have higher male expression in both ages. Quadrant IV 
contains genes that have exhibited sex-biased expression with higher male expression in the y-axis age and higher female expression 
in the x-axis age. Positive slopes of regression lines indicate that genes in one age with greater expression in one sex will have greater 
expression of the same sex in the other age. Note that all slopes, except for the comparison between one-month and four-months in 
muscle, are significant. 
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CHAPTER 2 
 SEX-BIASED GENE EXPRESSION OF GROWTH REGULATORY NETWORKS AND THE 
DEVELOPMENT OF SEXUAL SIZE DIMORPHISM 
ABSTRACT 
 Sexual size dimorphism is a form of phenotypic diversity that affects many aspects of a 
species’ evolutionary trajectory including physiology, ecology, and behavior among other life-
history traits. While sexual size dimorphism is common in nature, it should be difficult to evolve 
given that the sexes share an autosomal genome. One solution to this paradox is differential 
expression of shared genes between the sexes that could allow sexual dimorphism to evolve and, 
in particular, differential expression of growth-regulatory genes may be important for the 
evolution and development of sexual size dimorphism. We identified genes crucial to the growth 
hormone/insulin-like growth factor, insulin-signaling, and mechanistic target of rapamycin 
regulatory networks that regulate growth in vertebrates. Differential gene expression analysis of 
these growth regulatory networks revealed that tissue-specificity of differential expression of 
growth-regulatory genes drives the development of sexual size dimorphism.  
INTRODUCTION 
 One of the most common types of sexual dimorphism is sexual size dimorphism, 
whereby the sexes differ in adult body size. Given the role of body size as a fundamental 
determinant of physiological processes and ultimately fitness, understanding the evolution of 
sexual size dimorphism has been a major goal of evolutionary biology. Research has tended to 
focus on the evolutionary drivers of sexual size dimorphism. The evolution of sexual size 
dimorphism is likely driven by a combination of ecological evolutionary forces (Selander 1966; 
Shine 1989; Butler, Schoener & Losos 2000), natural selection (Darwin 1888; Cox, Skelly & 
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John‐Alder 2003), and sexual selection (Darwin 1888; Cox, Skelly & John‐Alder 2003). 
However, the repeated evolution of sexual size dimorphism is paradoxical, as the sexes share the 
constraint of a common genome.  
 An obstacle to evolving sexual size dimorphism is the central paradox of the 
development of sexual dimorphism: two distinct phenotypes must be produced from one shared 
genome (Lande 1980; Rice 1984; Fisher 1999; Badyaev 2002). In a sexually dimorphic species, 
genomic conflict will arise if selection promotes separate phenotypic optima for each sex (i.e., 
sexually antagonistic selection) but the genetic loci for divergent traits are the same for both 
sexes (i.e., intralocus sexual conflict) (Chippindale, Gibson & Rice 2001; Rice & Chippindale 
2001; Bonduriansky, Rowe & Tregenza 2005; Bonduriansky & Chenoweth 2009; Cox & 
Calsbeek 2009). Intralocus sexual conflict is expected to impede the divergence of the sexes to 
their phenotypic optima as the genetic influence on traits shared between the sexes (i.e., 
between-sex genetic correlations) is high, and for that reason, the sexes should be unable to 
diverge when selection for the female and male optima point in different directions resulting in a 
genomic tug-of-war (Lande 1980; Lande 1987; Fisher 1999; Bonduriansky & Chenoweth 2009; 
Poissant, Wilson & Coltman 2010). Given that sexual dimorphism and sexual size dimorphism 
are common in nature, there must be genetic mechanisms that reduce between sex genetic 
correlations for shared phenotypic traits to resolve genomic conflict and allow sexual 
dimorphism and sexual size dimorphism to evolve (Lande 1980; Lande 1987; Fairbairn & Roff 
2006). 
 The development of sexual size dimorphism must arise from sex-specific differences in 
regulatory processes that direct an individual’s growth (Sanger et al. 2013). One common 
mechanism that regulates the development of sexual size dimorphism in vertebrates is 
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differential production of systemic hormones. Oestrogen and testosterone, the two main sex 
hormones, are prominent regulators of the amount of growth and rate of growth is attained within 
each sex across vertebrate lineages (Badyaev 2002; Cox, Stenquist & Calsbeek 2009; Adkins-
Regan 2012). Although physiological mechanisms that regulate sexual size dimorphism, 
including hormonal mediation, are well understood, it is unclear how sexual size dimorphism is 
regulated by genetic mechanisms, enabling species to evolve sexual size dimorphism (Badyaev 
2002). 
 Several genetic mechanisms might facilitate the evolution and development of sexual 
dimorphism and sexual size dimorphism by resolving intralocus sexual conflict. Sex 
chromosomes, DNA molecules that determine the sex of an individual, can facilitate the 
evolution of sexual dimorphism when sexually antagonistic traits (traits beneficial to one sex and 
detrimental to the other) become sex-linked or sex-limited to the sex it benefits, thereby reducing 
or removing a genetic constraint on the impeded sex (Rice 1984; Van Doorn & Kirkpatrick 
2007; Roberts, Ser & Kocher 2009). Sex-specific transcript splicing can reduce intralocus sexual 
conflict by allowing a single locus to produce sex-specific gene products (Stewart, Pischedda & 
Rice 2010; Kijimoto, Moczek & Andrews 2012). Genomic imprinting is able to reduce between-
sex genetic correlations and intralocus sexual conflict by altering or silencing the expression of 
genes inherited from the parent of the opposite sex to allow independent selection on a locus for 
each sex (Day & Bonduriansky 2004; Bonduriansky 2007). Gene duplication, a genomic event 
where additional copies of genes are produced, may also reduce intrasexual conflict by 
generating copies of genes that gain sex-specific functions, thus becoming able to evolve 
independently and facilitate divergence between the sexes (Connallon & Clark 2011; Gallach & 
Betrán 2011). While all of these genetic mechanisms may be utilized to reduce between-sex 
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genetic correlations and intrasexual conflict, one mechanism is predicted to be particularly 
important to the reduction of intralocus sexual conflict: differential gene expression. 
 Because males and females are essentially genetically identical, with most sexes differing 
in a few genes on sex chromosomes or actually being genetically identical in systems with 
environmental sex-determination, it is expected that sexual dimorphism results mainly from 
differential expression of shared genes between the sexes (Ellegren & Parsch 2007; Mank 2009; 
Williams & Carroll 2009; Mank et al. 2010; Grath & Parsch 2016; Mank 2017). Differential 
expression of shared genes between the sexes (i.e., sex-biased gene expression) is predicted to 
reduce intralocus sexual conflict by allowing the sexes to produce distinct phenotypes through 
sex-specific expression patterns under the assumption that male-biased genes produce male traits 
and female-biased genes produce female traits (Ellegren & Parsch 2007; Mank 2009; Innocenti 
& Morrow 2010; Mank et al. 2010; Ingleby, Flis & Morrow 2015; Grath & Parsch 2016).  
 Large proportions of genes exhibit sex-biased expression (Zhang et al. 2007; Mank et al. 
2010), and the magnitude of sex-bias in gene expression has been linked to the magnitude of 
phenotypic sexual dimorphism (Pointer et al. 2013; Harrison et al. 2015). However, it is unclear 
what proportion of sex-biased genes are ultimately responsible for the development of sexual 
dimorphism and sexual size dimorphism. In vertebrates, the growth hormone/insulin-like growth 
factor (GH/IGF), insulin-signaling, and mechanistic target of rapamycin (mTOR) gene networks 
regulate growth, energetics, and cell proliferation and, therefore, are likely to contain genes 
whose differential expression between the sexes might be of particular importance in the brown 
anole’s development of sexual size dimorphism (Cox et al. 2017).  
 The growth hormone/insulin-like growth factor (GH/IGF) axis is a signaling pathway that 
regulates postnatal muscle and bone growth in vertebrates through a complex system of direct 
55 
 
 
 
influences and feedback interactions between growth hormone, insulin-like growth factors, and 
tissues that they act on (Giustina, Mazziotti & Canalis 2008; Perrini et al. 2010). The insulin-
signaling network is a crucial biological pathway that regulates glucose and lipid metabolism. 
Insulin regulates metabolism by stimulating glucose, fatty acid, and amino acid uptake into cells 
as well as promoting their synthesis and inhibiting their degradation (Saltiel & Kahn 2001). 
Insulin also stimulates protein synthesis and inhibits protein degradation by activating mTOR 
(Raught, Gingras & Sonenberg 2001).The mechanistic (formerly ‘‘mammalian’’) target of 
rapamycin (mTOR) signaling network revolves around the protein kinase mTOR which 
promotes cell growth and proliferation in eukaryotes through a large number of downstream 
targets (Hay & Sonenberg 2004; Saxton & Sabatini 2017).  
 Previous work examining ontogenetic changes in hepatic sex-biased gene expression in 
brown anoles has found that all three of these signaling pathways exhibit ontogenetic increases in 
the liver from subadult to adult life stages (Cox et al. 2017). In particular, the GH/IGF and 
mTOR pathways exhibit higher ontogenetic increases in sex-biased expression relative to the 
general trend of sex-biased expression (Cox et al. 2017). Differential expression of genes in 
these pathways in target tissues (e.g., expression of hormone receptors in musculoskeletal tissue) 
might be a key genetic mechanism that allows sexual size dimorphism to evolve (Ranz et al. 
2003; Emlen et al. 2006; McGlothlin & Ketterson 2008; Williams & Carroll 2009), however it is 
unknown how these pathways are differentially utilized between the sexes over ontogeny and 
across tissues important to the development of sexual size dimorphism.  
 We selected three a priori signaling pathways that regulate growth, metabolism, and cell 
proliferation in vertebrates to examine (1) the growth hormone/insulin-like growth factor 
(GH/IGF) axis, (2) insulin-signaling network, and (3) the mechanistic target of rapamycin 
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(mTOR) gene networks. An illustration of how these pathways interact in the liver is provided in 
Figure 2.1. Exploring sex-biased gene expression patterns of these pathways will uncover how 
complex physiological traits like growth are regulated over time and coordinated among tissues 
to avoid intralocus sexual conflict and directly connect sex-biased gene expression to sexually 
dimorphic phenotypes. 
 We used a targeted approach to characterize the differential gene expression basis of 
sexual size dimorphism and examined the expression of the GH/IGF axis, insulin-signaling, and 
mTOR growth regulatory signaling pathways. We sought to answer these questions: (1) How do 
the sexes differ in expression of growth regulatory signaling pathways important to the 
regulation of growth? (2) How do sex-specific expression patterns of growth regulatory signaling 
pathways change over time? (3) How do tissues important to the development of sexual 
dimorphism differ in expression of growth regulatory signaling pathways? (4) How does 
expression of growth regulatory signaling pathways within tissues change over time? We 
predicted: (1) Sex-biased expression of growth regulatory signaling pathways would generally be 
male-biased in direction as male brown anoles experience higher rates of growth and attain larger 
body size relative to female brown anoles. (2) Expression levels of growth regulatory signaling 
pathways would increase over time for both sexes as they develop from juveniles to adults, but 
male expression levels would increase more over time as they grow larger than females. (3) As 
an upstream regulator of these networks, the brain should exhibit more expression of upstream 
components of growth regulatory signaling pathways relative to the liver and muscle, which 
should exhibit expression of downstream components of growth regulatory signaling pathways. 
In addition, the brain should not exhibit as much sex-biased gene expression relative to the liver 
and muscle as small amounts of upstream component expression can enact large downstream 
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effects and, therefore, the brain may not require sex-biased expression of growth regulatory 
signaling pathways to regulate development of sexual size dimorphism. 4) The brain should 
exhibit relatively constant levels of expression of growth regulatory signaling pathways over 
time as an upstream regulator, and we expect that liver and muscle expression of growth 
regulatory signaling pathways will increase over time as the sexes grow. In addition, the liver 
and muscle and should show the greatest increases in expression at eight and twelve months, the 
two ages with the greatest amount of growth for both sexes. 
MATERIALS AND METHODS 
Study System 
 We focused on the brown anole, which exhibits male-biased extreme sexual size 
dimorphism. We used laboratory-raised brown anoles, descended from a wild population in The 
Bahamas, to collect tissues important to growth and assess gene expression patterns. For 
additional information see Materials and Methods of Chapter 1. 
Animal husbandry 
 Animals were cared for in a vivarium at the University of Virginia in Charlottesville, 
Virginia. Animals were housed separately, watered twice daily, and fed a diet of crickets, amount 
and frequency depending on age and sex of the individual. Environmental conditions were kept 
at levels meant to replicate natural conditions. For additional information see Materials and 
Methods of Chapter 1. 
Tissue Collection 
 Liver, femoral muscle, and brain were collected from male and female brown anoles of 
ages one, four, eight, and twelve months. Animals were euthanized by decapitation, a method 
approved by the University of Virginia Animal Care and Use Committee (Protocol 3896). 
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Following euthanasia, animals were dissected and tissues of interest were placed in RNAlater 
solution to preserve RNA integrity. For additional information see Materials and Methods of 
Chapter 1. 
RNA Isolation and Sequencing 
 Tissue samples were transported, on dry ice, to Georgia Southern University in 
Statesboro, Georgia. Total RNA was extracted from all samples utilizing a TRIzol reagent 
protocol. RNA from one-month-old anoles were pooled to meet minimum RNA concentrations 
required for sequencing. RNA samples were submitted to the Georgia Genomics Facility at the 
University of Georgia and sequenced on the Illumina NextSeq 500 platform. For additional 
information see Materials and Methods of Chapter 1. 
Transcriptome Assembly and RNA-Seq Analysis 
 RNA-Seq data were quality filtered, mapped to the Anolis carolinensis genome, and 
analyzed for differential expression of genes predicted to be important to the development of 
sexual size dimorphism in brown anoles using several bioinformatic programs. For additional 
information see Materials and Methods of Chapter 1. 
Assembly of Growth Gene Networks. 
 In this targeted approach, we a priori selected the growth hormone/insulin-like growth 
factor (GH/IGF) network, the mechanistic target of rapamycin (mTOR) network, and the 
insulin-signaling network to examine for differential gene expression between the liver, muscle, 
and brain tissues of male and female brown anoles across their development. These signaling 
pathways regulate growth, energetics, and cell proliferation in vertebrates and are likely to be 
differentially utilized in brown anoles, a system that exhibits extreme sexual size dimorphism. 
We used the KEGG database (Kanehisa & Goto 2000; Kanehisa et al. 2004) and WikiPathways 
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(Kelder et al. 2011) to identify and assemble genes annotated to belong to these networks and 
developed an a priori list of 114 genes (hereafter “growth genes”; Table 2.1), five of which that 
had two splice variants. Tables 2.2 through 2.4 contain the individual networks and the growth 
genes that belong to them. 
Statistical Methods 
 In addition to differential gene expression analysis, we used general linear models to test 
for differences in mean expression of the GH/IGF, insulin-signaling, and mTOR growth 
networks between sexes, ages, and tissues. We also tested for differences in mean expression 
levels of several growth genes crucial to our a priori selected growth networks between sexes, 
between ages, and between tissues. 
RESULTS 
 The liver and muscle exhibited sex-biased expression of growth genes while the brain 
exhibited no sex-biased expression of any growth gene belonging to the GH/IGF, mTOR, and 
insulin-signaling networks a priori selected as being important to the development of sexual size 
dimorphism in the brown anole. The exact growth genes, broken down by age, that exhibited 
sex-biased expression in liver and muscle can be found in Table 2.5 and Table 2.6, respectively.  
Amount of Sex-biased Growth Genes 
 In the liver (Figure 2.2A), the number of growth genes that exhibited sex-biased 
expression increased for both sexes over time. Neither sex exhibited sex-biased expression of 
growth genes at the one-month age point, but the number of growth genes with sex-biased 
expression continually increased to reach 14 in male livers and six in female livers at the twelve-
month age point. The number of growth genes with sex-biased expression per sex was equal in 
the one- and four-month age points, but in the eight- and twelve-month age points the number of 
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growth genes with male sex-biased expression was more than double the number of growth 
genes with female-biased expression. 
 In the femoral muscle, the number of growth genes that exhibit sex-biased expression 
increased for both sexes over time (Figure 2.2B). Neither sex exhibited sex-biased expression of 
growth genes at the one-month age point, but the number of growth genes that exhibited sex-
biased expression continually increased to reach nine in female femoral muscle and five in male 
femoral muscle at the twelve-month age point. The femoral muscle had a different pattern of sex-
biased growth gene expression from the liver in that the difference in number of growth genes 
that exhibited sex-biased expression between the sexes was not as extreme and there were more 
growth genes with female-biased expression than growth genes with male-biased expression 
across ontogeny (Figure 2.2). 
Tissue-specific Growth Gene Patterns 
 The liver and femoral muscle both exhibited divergent patterns of sex-biased growth gene 
expression. In the liver (Table 2.5), approximately half of the growth genes that exhibited sex-
biased expression were growth genes that exhibited sex-biased expression over multiple age 
points. In the muscle (Table 2.6), only 4 out of 25 growth genes that exhibited sex-biased 
expression were genes that exhibited sex-bias at multiple age points. Additionally, the insulin-
like growth factor pathway was disproportionately represented in the liver compared to the 
muscle. In the liver, insulin-like growth factors 1 and 2 both experienced male-biased expression 
across the four-, eight-, and twelve-month age points as well as several of their binding proteins. 
In the muscle, insulin-like growth factor 1 only exhibited sex-biased expression in eight-month-
old males and insulin-like growth factor 2 exhibited no sex-biased expression for either sex at 
any age point. However, there was male sex-biased expression of insulin-like growth factor 2 
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binding protein 2 at eight months and female-biased expression of insulin-like growth factor 
binding proteins 4 and 7 at twelve months. 
Growth Gene Expression Levels 
 The expression levels of all growth genes were similar between males and females within 
all tissues and that expression remained consistent across each age point within each tissue. In 
the liver (Figure 2.3A), mean growth gene expression did not differ between the sexes (F(1,3800) = 
0.136, P =0.713) or ages (F(3,3800) = 0.836, P =0.474) and there was no interaction between sex or 
age (F(3,3800) = 0.148, P = 0.931). In the muscle (Figure 2.3B), mean growth gene expression did 
not differ between the sexes (F(1,3800) = 0.093, P = 0.760) or ages (F(3,3800) = 1.305, P = 0.271) and 
there was no interaction between sex or age (F(3,3800) = 0.472, P = 0.702). In the brain (Figure 
2.3C), mean growth gene expression did not differ between the sexes (F(1,3800) = 0.037, P = 
0.848) or ages (F(3,3800) = 0.076, P = 0.973) and there was no interaction between sex or age 
(F(3,3800) = 0.025, P = 0.995). Although sexes and ages did not differ in mean growth gene 
expression levels within tissues, the tissues did differ in mean growth gene expression level 
between each other (F(2,11421) = 83.68, P < 0.0001). These results indicate that while there were 
no sex- or age-specific patterns of mean growth gene expression there were tissue-specific 
patterns that differ from each other. 
Sex-biased Growth Gene Expression Levels 
 The expression levels of growth genes that were sex-biased in expression exhibit 
divergent patterns in the liver and muscle (Figure 2.4). Due to both liver and muscle gene 
expression data violating the assumption of homogeneity of variance (Brown-Forsythe test 
statistics all less than 0.05), before and after log transformation, we adjusted our alpha level to 
0.01 to compensate and further adjusted the alpha level to 0.005 using a Bonferroni correction (n 
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= 2). In the liver (Figure 2.4A), mean expression of growth genes exhibiting sex-biased 
expression differed between ages (F(2,494) = 7.325, P < 0.0001) but did not differ between the 
sexes (F(1,494) = 5.169, P = 0.02342) and there was no an interaction between sex and age (F(2,494) 
= 0.001, P = 0.99881). In the muscle (Figure 2.4B), mean expression of growth genes exhibiting 
sex-biased expression differed between ages (F(2,264) = 8.257, P = 0.00033) with a significant 
interaction between sex and age (F(2,264) = 5.770, P = 0.00353) but did not differ between sexes 
(F(1,264) = 0.002, P = 0.96096). These results may be indicative of a temporal trajectory of sex-
biased growth gene expression within tissues as ages significantly differed in mean sex-biased 
growth gene expression while the sexes did not. 
Growth Gene Network Expression 
 For all three networks, there were differences in mean expression among tissues (all p-
values < 0.0001), however there were no significant differences in mean expression of any these 
networks between the sexes or between ages with no significant interactions between. Full 
results are available in Table 2.7. 
Expression of Growth Hormone Receptor and Growth Factors 
 The expression of growth hormone receptor (GHR; Figure 2.5) increased in both the liver 
and muscle across ontogeny, but not the brain. GHR significantly differed in mean expression 
between ages (F(3,72) = 14.694, P < 0.0001) and between tissues (F(2,72) = 307.124, P < 0.0001) 
and had a significant interaction between age and tissue (F(6,72) = 4.89, P < 0.0001). GHR did not 
significantly differ in mean expression between sexes or have other significant interactions (all 
p-values > 0.05; Table 2.7). The expression of insulin-like growth factor 1 (IGF1; Figure 2.6) 
increasingly diverged between the sexes throughout ontogeny and was heavily male-biased 
through ages four, eight, and twelve months. IGF1 significantly differed in mean expression 
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between the sexes (F(1,72) = 66.810, P < 0.0001) and between tissues (F(2,72) = 85.173, P < 0.0001) 
with a significant interaction between sex and tissue (F(2,72) = 62.225, P < 0.0001). The 
expression of insulin-like growth factor 2 (IGF2; Figure 2.6) had a similar pattern to IGF1, being 
highly divergent in the liver relative to muscle and brain. IGF2 significantly differed in mean 
expression between sexes (F(1,72) = 33.250, P < 0.0001), between ages (F(3,72) = 6.049, P < 
0.0010), and between tissues (F(2,72) = 66.810, P < 0.0001). The interactions between sex and 
tissue (F(2,72) = 33.117, P < 0.0001) and age and tissue (F(6,72) = 6.079, P < 0.0001) were also 
significant while interactions involving both sex and age are not. 
Expression of Growth Factor Binding Proteins and Receptor 
  The insulin-like growth factor binding proteins one through seven (IGFBP1-7) varied in 
their sex-, age-, and tissue-specific patterns (Figure 2.7; Table 2.8). All IGFBPs had significant 
differences in mean expression between tissues, while IGFBP2, IGFBP4, and IGFBP5 also had 
significant differences between sexes. IGFBP2 and IGFBP4 additionally both had significant 
differences in mean expression between ages while the other IGFBPs did not. All possible 
interactions had at least one IGFBP where they were significant except for the sex and age 
interaction that was not significant in any IGFBP. The Anolis carolinensis genome has two splice 
variants for the insulin-like growth factor 1 receptor (IGF1R): IGF1R-201 and IGF1R-202. 
Overall expression of IGF1R was much lower compared to other target growth genes (Figure 
2.8). Both splice variants significantly differed in mean gene expression between tissues (Table 
2.8) but did not significantly differ between sexes or between ages with no significant 
interactions between factors. 
Expression of Insulin-signaling and mTOR 
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 The Anolis carolinensis genome did not have an annotated insulin receptor ortholog at 
the time of transcriptome assembly, so we examined the expression of insulin receptor substrate 
1 (IRS1) and insulin receptor substrate 4 (IRS4; Figure 2.9) which both bind to insulin receptor. 
IRS1 only significantly differed in mean expression between tissues (F(2,72) = 439.672, P < 
0.0001) with no significant differences between sexes or ages and no significant interactions. 
IRS4 significantly differed in mean expression between ages (F(3,72) = 6.465, P = 0.00062) and 
tissues (F(2,72) = 62.057, P < 0.0001) with significant interactions between sex and age (F(3,72) = 
5.030, P = 0.00320), age and tissue (F(6,72) = 5.387, P = 0.00012), and between sex, age, and 
tissue (F(6,72) = 3.684, P = 0.00301). The mechanistic target of rapamycin (mTOR) was expressed 
at a similar level within the muscle and brain but not the liver across age points for both sexes 
(Figure 2.10). mTOR only significantly differed in mean expression between ages (F(3,72) =8.929, 
P < 0.0001) and between tissues (F(2,72) = 63.052, P < 0.0001) with a significant interaction 
between age and tissue (F(6,72) = 6.936, P < 0.0001; Table 2.3). 
DISCUSSION 
 Determining the relationship between differences in gene expression and differences in 
phenotype is one of the outstanding questions in the study of the molecular basis of sexual 
dimorphism (Mank 2017). As sexual dimorphism is essentially a form of polyphenism, the 
relationship between gene expression and phenotype is also fundamental to understanding the 
evolution of phenotypic diversity and speciation (Nijhout 2003; West-Eberhard 2003). Crucially, 
the role of genes that are sex-biased in expression in the development and evolution of sexual 
dimorphism is unclear. Large proportions of the genome are genes that exhibit sex-biased 
expression (Zhang et al. 2007; Mank et al. 2010) and while there are relationships between the 
magnitude of sex-biased gene expression and phenotypic dimorphism (Pointer et al. 2013; 
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Harrison et al. 2015), we found no causal relationships between total number of genes with sex-
biased expression and phenotypic dimorphism. Given that there is significant variation in amount 
of sex-biased gene expression and impact of individual loci, it is likely that there are subsets of 
genes that contribute more to sexual dimorphism.  
 We found that many genes in the growth hormone/insulin-like growth factor (GH/IGF) 
axis increased in sex-biased expression during development. The GH/IGF axis is a signaling 
pathway that regulates postnatal muscle and bone growth in vertebrates through a complex 
system of direct influences and feedback interactions between growth hormone, insulin-like 
growth factors, and tissues that they act on (Giustina, Mazziotti & Canalis 2008; Perrini et al. 
2010). Growth hormone (GH) is a peptide hormone synthesized in and secreted from the anterior 
pituitary gland in the brain. Its binding to growth hormone receptor (GHR), which is highly 
expressed in the liver and skeletal muscle as well as the heart, lungs, kidneys, pancreas, intestine, 
and cartilage, initiates signal transduction and GH’s primary method of action: synthesis of 
insulin-like growth factor 1 (IGF1). IGF1 is a complex growth-promoting hormone that has a 
similar structure to insulin and acts as both a systemic hormone and as a localized growth factor 
(Melmed 1999). Systemic IGF1 is synthesized in the liver as an endocrine hormone and is GH 
dependent while localized synthesis of IGF1 outside of the liver is regulated by a variety of other 
hormones (Melmed 1999). IGF1 binds to IGF1 binding proteins which alter IGF1’s interaction 
with cell surface receptors, and then binds to the IGF1 receptor, a transmembrane cell surface 
receptor that mediates IGF1’s effects to promote growth and cell proliferation across somatic 
tissues (Ohlsson et al. 2009). Insulin-like growth factor 2 (IGF2) is a similar peptide hormone to 
IGF1 and is thought to primarily promote prenatal growth (Giustina, Mazziotti & Canalis 2008) 
but may more generally promote growth across ontogeny in reptiles (McGaugh et al. 2015; Cox 
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et al. 2017). Surprisingly, ontogenetic increases in size (Figure 1.1) were not accompanied by 
ontogenetic increases in expression of the GH/IGF network (Figure 2.11). Across the whole 
GH/IGF network, the only significant difference in mean gene expression was between tissues 
with no significant interactions between any factors (Table 2.3). These results suggest that the 
whole GH/IGF network may be regulated by tissue-specific patterns that are constant between 
the sexes throughout ontogeny. However, the number of genes with sex-biased expression in this 
network increased in the liver (Table 2.1) and muscle (Table 2.2) across ontogeny, which 
suggests that sex-biased expression of only a subset of genes in the GH/IGF network may be 
required to direct the GH/IGF pathway’s involvement in development of sexual size 
dimorphism. Additionally, we found that IGF2 expression increased throughout ontogeny in both 
sexes, providing support for IGF2’s role in reptilian growth across ontogeny (McGaugh et al. 
2015). 
 The insulin-signaling network is a crucial biological pathway that regulates glucose and 
lipid metabolism. Insulin regulates metabolism by stimulating glucose, fatty acid, and amino acid 
uptake into cells as well as promoting their synthesis and inhibiting their degradation (as 
reviewed in (Saltiel & Kahn 2001). Insulin also stimulates protein synthesis and inhibits protein 
degradation by activating mTOR (Raught, Gingras & Sonenberg 2001). We found that mean 
expression of the whole insulin-signaling network (Figure 2.12) only significantly differed 
between tissues (Table 2.3) and not between the sexes or between ages. Similar to the GH/IGF 
pathway, this may indicate that expression of the insulin-signaling network is directed by tissue-
specific and not sex- or age-specific trajectories to direct growth of sexual size dimorphism. 
However, there was sex-biased expression of genes in the insulin-signaling pathway throughout 
ontogeny in both the liver and muscle (Table 2.) 
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 The mechanistic (formerly ‘‘mammalian’’) target of rapamycin (mTOR) signaling 
network revolves around the protein kinase mTOR which promotes cell growth and proliferation 
in eukaryotes through a large number of downstream targets (Hay & Sonenberg 2004; Saxton & 
Sabatini 2017). mTOR is able to regulate protein synthesis by phosphorylating/inactivating the 
mRNA translation inhibitor 4E-BP1 (Brunn et al. 1996) and phosphorylating/activating S6 
Kinase which promotes mRNA translation initiation and cell proliferation (Brown et al. 1995). 
mTOR further facilitates cell growth by promoting lipid synthesis for cell membrane formation 
and expansion (Porstmann et al. 2008), nucleotide synthesis for DNA replication and ribosome 
generation (Ben-Sahra et al. 2013; Robitaille et al. 2013; Ben-Sahra et al. 2016), and glucose 
metabolism (Düvel et al. 2010; Saxton & Sabatini 2017). In addition to numerous other roles in 
regulating cell growth and proliferation (reviewed in (Hay & Sonenberg 2004; Saxton & Sabatini 
2017), mTOR is associated with muscle hypertrophy (Anthony et al. 2000; Bodine et al. 2001) 
and may promote muscle growth as a downstream target of IGF1 (Rommel et al. 2001). 
We found that mean expression of the whole mTOR network (Figure 2.13) only differed 
between tissues and not between the sexes or between ages (Table 2.3). However, elements of 
the mTOR network experienced sex-biased expression in the liver and muscle throughout 
ontogeny. These results may indicate that tissue-specific patterns of expression of the whole 
network and sex-biased expression of key genes over ontogeny in the pathway coordinate the 
mTOR network’s contribution to the development of sexual size dimorphism in the brown anole. 
 Sexual dimorphism is predicted to be difficult to evolve due to the buildup of between-
sex genetic correlations due to a shared genome between the sexes. However differential 
expression of shared genes can reduce between-sex genetic correlations and allow sexual 
dimorphism to evolve. Large proportions of the genome exhibit sex-biased gene expression but it 
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is unclear what proportion of sex-biased genes are actually important to the development of 
sexual dimorphism. We examined the expression of 114 growth genes in the GH/IGF, insulin, 
and mTOR signaling pathways, that we predicted to be important to growth and development of 
sexual size dimorphism in the brown anole, in liver, muscle, and brain to uncover sex-, age-, and 
tissue-specific patterns. We predicted the sexes to exhibit high levels of sex-biased expression of 
these genes that increase over ontogeny in order to facilitate the development of their sexual size 
dimorphism. Indeed, we found that male and female brown anoles differentially expressed genes 
in these pathways in the liver and muscle, but not the brain, throughout ontogeny. We found that 
only 43.7% of the growth genes we examined exhibit sex-biased expression in at least one of 
three functionally diverse tissues important to growth. However, we chose to examine genes 
known to be strong effectors of growth, thus the sexes may not require a larger proportion of 
growth genes to be sex-biased in expression to develop sexual size dimorphism. Furthermore, 
when we tested for sex-, age-, and tissue-specific effects on gene expression of entire growth 
networks, we only found significant differences between tissues. Although these networks are 
crucial to the development of sexual size dimorphism, the sexes did not differ in expression 
levels of these growth networks. Combined with the low number of growth genes that exhibit 
sex-biased expression, these results suggest that sex-biased expression of only relatively few 
growth genes across three signaling pathways important to growth are required to develop sexual 
size dimorphism in brown anoles. More broadly, these results suggest that, despite large 
proportions of the genome exhibiting sex-biased gene expression, sex-biased expression of 
relatively few genes, albeit genes that exert strong effects, are enough to reduce between-sex 
genetic correlations and allow sexual dimorphism to develop. Thus, the genetic constraint of a 
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shared genome might be relatively easy to overcome, explaining the ubiquity of sexual 
dimorphism despite the genomic paradox of producing two phenotypes from a single genome. 
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Table 2.1 A list of all 114 a priori growth genes found in the growth hormone/insulin-like 
growth factor (GH/IGF), insulin-signaling, and mechanistic target of rapamycin (mTOR) 
networks. Gene IDs ending in “.1” and “.2” reflect the 201 splice variant and 202 splice variant 
of the gene, respectively. 
Ensembl transcript ID Gene ID Ensembl description 
ENSACAT00000010700 GHR Growth Hormone Receptor [Source:Hgnc Symbol;Acc:4263] 
ENSACAT00000006111 GHRRH Growth Hormone Releasing Hormone Receptor [Source:Hgnc 
Symbol;Acc:4266] 
ENSACAT00000016563 IGF1 Insulin-Like Growth Factor 1 (Somatomedin C) [Source:Hgnc 
Symbol;Acc:5464] 
ENSACAT00000008062 IGFBP1 Insulin-Like Growth Factor Binding Protein 1 [Source:Hgnc 
Symbol;Acc:5469] 
ENSACAT00000004558 IGFBP2 Insulin-Like Growth Factor Binding Protein 2, 36Kda [Source:Hgnc 
Symbol;Acc:5471] 
ENSACAT00000008083 IGFBP3 Insulin-Like Growth Factor Binding Protein 3 [Source:Hgnc 
Symbol;Acc:5472] 
ENSACAT00000016203 IGFBP4 Insulin-Like Growth Factor Binding Protein 4 [Source:Hgnc 
Symbol;Acc:5473] 
ENSACAT00000000083 IGFBP5 Insulin-Like Growth Factor Binding Protein 5 [Source:Hgnc 
Symbol;Acc:5474] 
ENSACAT00000029049 IGFBP6 Insulin-Like Growth Factor Binding Protein 6 [Source:Hgnc 
Symbol;Acc:5475] 
ENSACAT00000002051 IGFBP7 Insulin-Like Growth Factor Binding Protein 7 [Source:Hgnc 
Symbol;Acc:5476] 
ENSACAT00000029347 IGF1R.1 Insulin-Like Growth Factor 1 Receptor [Source:Hgnc 
Symbol;Acc:5465] 
ENSACAT00000008235 IGF1R.2 Insulin-Like Growth Factor 1 Receptor [Source:Hgnc 
Symbol;Acc:5465] 
ENSACAT00000009701 IGF2 Insulin-Like Growth Factor 2 (Somatomedin A) [Source:Hgnc 
Symbol;Acc:5466] 
ENSACAT00000006271 IGF2BP1 Insulin-Like Growth Factor 2 Mrna Binding Protein 1 [Source:Hgnc 
Symbol;Acc:28866] 
ENSACAT00000008070 IGF2BP2 Insulin-Like Growth Factor 2 Mrna Binding Protein 2 [Source:Hgnc 
Symbol;Acc:28867] 
ENSACAT00000013612 IGF2BP3 Insulin-Like Growth Factor 2 Mrna Binding Protein 3 [Source:Hgnc 
Symbol;Acc:28868] 
ENSACAT00000011634 AKT1 Akt Serine/Threonine Kinase 1 [Source:Hgnc Symbol;Acc:Hgnc:391] 
ENSACAT00000002209 Cbl Cbl Proto-Oncogene [Source:Hgnc Symbol;Acc:Hgnc:1541] 
ENSACAT00000004315 CDKN1B Cyclin-Dependent Kinase Inhibitor 1B (P27, Kip1) [Source:Hgnc 
Symbol;Acc:1785] 
ENSACAT00000029358 EIF4EBP1 Eukaryotic Translation Initiation Factor 4E Binding Protein 1 
[Source:Hgnc Symbol;Acc:3288] 
ENSACAT00000014236 EIF4E Eukaryotic Translation Initiation Factor 4E [Source:Hgnc 
Symbol;Acc:3287] 
ENSACAT00000017135 GYS2 Glycogen Synthase 2 [Source:Hgnc Symbol;Acc:Hgnc:4707] 
ENSACAT00000004836 GYS1 Glycogen Synthase 1 [Source:Hgnc Symbol;Acc:Hgnc:4706] 
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ENSACAT00000004723 ELK1 Ets Transcription Factor [Source:Hgnc Symbol;Acc:Hgnc:3321] 
ENSACAT00000009932 FASN Fatty Acid Synthase [Source:Hgnc Symbol;Acc:Hgnc:3594] 
ENSACAT00000013303 FBP1 Fructose-Bisphosphatase 1 [Source:Hgnc Symbol;Acc:Hgnc:3606] 
ENSACAT00000008015 FLOT2 Flotillin 2 [Source:Ncbi Gene;Acc:100563055] 
ENSACAT00000017291 FLOT1 Flotillin 1 [Source:Hgnc Symbol;Acc:Hgnc:3757] 
ENSACAT00000001070 G6PC2 Glucose-6-Phosphatase Catalytic Subunit 2 [Source:Hgnc 
Symbol;Acc:Hgnc:28906] 
ENSACAT00000007397 GNL3.1 G Protein Nucleolar 3 [Source:Hgnc Symbol;Acc:Hgnc:29931] 
ENSACAT00000026449 GNL3.2 G Protein Nucleolar 3 [Source:Hgnc Symbol;Acc:Hgnc:29931] 
ENSACAT00000006564 GRB2 Growth Factor Receptor-Bound Protein 2 [Source:Hgnc 
Symbol;Acc:4566] 
ENSACAT00000016466 RAPGEF2 Rap Guanine Nucleotide Exchange Factor 2 [Source:Hgnc 
Symbol;Acc:Hgnc:16854] 
ENSACAT00000013894 RAPGEF1 Rap Guanine Nucleotide Exchange Factor 1 [Source:Ncbi 
Gene;Acc:100558908] 
ENSACAT00000029738 GSK3B.1 Glycogen Synthase Kinase 3 Beta [Source:Hgnc 
Symbol;Acc:Hgnc:4617] 201 Splice Variant 
ENSACAT00000003712 GSK3B.2 Glycogen Synthase Kinase 3 Beta [Source:Hgnc 
Symbol;Acc:Hgnc:4617] 202 Splice Variant 
ENSACAT00000007957 HSL Hormone Sensitive Lipase 
ENSACAT00000003820 IRS1 Insulin Receptor Substrate 1 [Source:Hgnc Symbol;Acc:6125] 
ENSACAT00000012637 IRS4 Insulin Receptor Substrate 4 [Source:Hgnc Symbol;Acc:6128] 
ENSACAT00000000408 MAP2K2 Mitogen-Activated Protein Kinase Kinase 2 [Source:Hgnc 
Symbol;Acc:6842] 
ENSACAT00000001764 MAP2K3 Mitogen-Activated Protein Kinase Kinase 3 [Source:Hgnc 
Symbol;Acc:6843] 
ENSACAT00000017532 MAP2K4 Mitogen-Activated Protein Kinase Kinase 4 [Source:Hgnc 
Symbol;Acc:6844] 
ENSACAT00000010177 MAP2K5 Mitogen-Activated Protein Kinase Kinase 5 [Source:Hgnc 
Symbol;Acc:6845] 
ENSACAT00000030866 MAP2K6 Mitogen-Activated Protein Kinase Kinase 6 [Source:Hgnc 
Symbol;Acc:6846] 
ENSACAT00000009956 MAP2K7 Mitogen-Activated Protein Kinase Kinase 7 [Source:Hgnc 
Symbol;Acc:6847] 
ENSACAT00000013773 MLST8 Mtor Associated Protein, Lst8 Homolog (S. Cerevisiae) [Source:Hgnc 
Symbol;Acc:24825] 
ENSACAT00000010374 MYC Myc Proto-Oncogene, Bhlh Transcription Factor [Source:Hgnc 
Symbol;Acc:Hgnc:7553] 
ENSACAT00000013790 NR3C1 Nuclear Receptor Subfamily 3, Group C, Member 1 (Glucocorticoid 
Receptor) [Source:Hgnc Symbol;Acc:7978] 
ENSACAT00000017591 PDE3A Phosphodiesterase 3A [Source:Hgnc Symbol;Acc:Hgnc:8778] 
ENSACAT00000003554 PDPK1 3-Phosphoinositide Dependent Protein Kinase-1 [Source:Hgnc 
Symbol;Acc:8816] 
ENSACAT00000016391 PCK1 Phosphoenolpyruvate Carboxykinase 1 [Source:Hgnc 
Symbol;Acc:Hgnc:8724] 
ENSACAT00000001275 PCK2 Phosphoenolpyruvate Carboxykinase 2, Mitochondrial [Source:Hgnc 
Symbol;Acc:Hgnc:8725] 
ENSACAT00000004827 PPARA Peroxisome Proliferator Activated Receptor Alpha [Source:Hgnc 
Symbol;Acc:Hgnc:9232] 
ENSACAT00000011918 PHKA2 Phosphorylase Kinase Regulatory Subunit Alpha 2 [Source:Hgnc 
Symbol;Acc:Hgnc:8926] 
80 
 
 
 
 
ENSACAT00000014131 PHKB Phosphorylase Kinase Regulatory Subunit Beta [Source:Hgnc 
Symbol;Acc:Hgnc:8927] 
ENSACAT00000004979 PIK3CA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase, Catalytic Subunit 
Alpha [Source:Hgnc Symbol;Acc:8975] 
ENSACAT00000017770 PIK3R5.1 Phosphoinositide-3-Kinase, Regulatory Subunit 5 [Source:Hgnc 
Symbol;Acc:30035] 
ENSACAT00000029838 PIK3R5.2 Phosphoinositide-3-Kinase, Regulatory Subunit 5 [Source:Hgnc 
Symbol;Acc:30035] 
ENSACAT00000006498 PRKCH Protein Kinase C, Eta [Source:Hgnc Symbol;Acc:9403] 
ENSACAT00000015152 PTEN Phosphatase And Tensin Homolog [Source:Hgnc Symbol;Acc:9588] 
ENSACAT00000014006 PYG Glycogen Phosphorylase 
ENSACAT00000012973 RAC1 Rac Family Small Gtpase 1 [Source:Hgnc Symbol;Acc:Hgnc:9801] 
ENSACAT00000016135 RAC2 Rac Family Small Gtpase 2 [Source:Hgnc Symbol;Acc:Hgnc:9802] 
ENSACAT00000029270 RAF1.1 Raf-1 Proto-Oncogene, Serine/Threonine Kinase [Source:Hgnc 
Symbol;Acc:Hgnc:9829] 
ENSACAT00000013316 RAF1.2 Raf-1 Proto-Oncogene, Serine/Threonine Kinase [Source:Hgnc 
Symbol;Acc:Hgnc:9829] 
ENSACAT00000004483 RASD1 Ras, Dexamethasone-Induced 1 [Source:Hgnc Symbol;Acc:15828] 
ENSACAT00000002273 Rheb Ras Homolog, Mtorc1 Binding [Source:Hgnc Symbol;Acc:Hgnc:10011] 
ENSACAT00000014310 RHO Rhodopsin [Source:Hgnc Symbol;Acc:10012] 
ENSACAT00000010084 RICTOR Rptor Independent Companion Of Mtor, Complex 2 [Source:Hgnc 
Symbol;Acc:28611] 
ENSACAT00000013049 RPS6KB1 Ribosomal Protein S6 Kinase B1 [Source:Hgnc 
Symbol;Acc:Hgnc:10436] 
ENSACAT00000016838 RPS6KL1 Ribosomal Protein S6 Kinase-Like 1 [Source:Hgnc Symbol;Acc:20222] 
ENSACAT00000015640 RPTOR Regulatory Associated Protein Of Mtor, Complex 1 [Source:Hgnc 
Symbol;Acc:30287] 
ENSACAT00000014553 SHBG Sex Hormone-Binding Globulin [Source:Hgnc Symbol;Acc:10839] 
ENSACAT00000015879 SHC1 Shc Adaptor Protein 1 [Source:Hgnc Symbol;Acc:Hgnc:10840] 
ENSACAT00000012679 SHC2 Shc Adaptor Protein 2 [Source:Ncbi Gene;Acc:100553545] 
ENSACAT00000005997 SHC4 Shc Adaptor Protein 4 [Source:Hgnc Symbol;Acc:Hgnc:16743] 
ENSACAT00000014599 SOCS1 Suppressor Of Cytokine Signaling 1 [Source:Hgnc 
Symbol;Acc:Hgnc:19383] 
ENSACAT00000012617 SOCS2 Suppressor Of Cytokine Signaling 2 [Source:Hgnc 
Symbol;Acc:Hgnc:19382] 
ENSACAT00000016743 SOCS3 Suppressor Of Cytokine Signaling 3 [Source:Hgnc 
Symbol;Acc:Hgnc:19391] 
ENSACAT00000016330 SOCS4 Suppressor Of Cytokine Signaling 4 [Source:Hgnc 
Symbol;Acc:Hgnc:19392] 
ENSACAT00000004217 SOCS5 Suppressor Of Cytokine Signaling 5 [Source:Hgnc 
Symbol;Acc:Hgnc:16852] 
ENSACAT00000011543 SOCS6 Suppressor Of Cytokine Signaling 6 [Source:Hgnc 
Symbol;Acc:Hgnc:16833] 
ENSACAT00000007427 SOCS7 Suppressor Of Cytokine Signaling 7 [Source:Hgnc 
Symbol;Acc:Hgnc:29846] 
ENSACAT00000006394 SOS1 Sos Ras/Rac Guanine Nucleotide Exchange Factor 1 [Source:Hgnc 
Symbol;Acc:Hgnc:11187] 
ENSACAT00000001643 SOS2 Sos Ras/Rho Guanine Nucleotide Exchange Factor 2 [Source:Hgnc 
Symbol;Acc:Hgnc:11188] 
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ENSACAT00000006298 STAT1 Signal Transducer And Activator Of Transcription 1, 91Kda 
[Source:Hgnc Symbol;Acc:11362] 
ENSACAT00000025425 STAT2 Signal Transducer And Activator Of Transcription 2, 113Kda 
[Source:Hgnc Symbol;Acc:11363] 
ENSACAT00000018021 STAT3 Signal Transducer And Activator Of Transcription 3 (Acute-Phase 
Response Factor) [Source:Hgnc Symbol;Acc:11364] 
ENSACAT00000009792 STAT6 Signal Transducer And Activator Of Transcription 6, Interleukin-4 
Induced [Source:Hgnc Symbol;Acc:11368] 
ENSACAT00000014051 STK11 Serine/Threonine Kinase 11 [Source:Hgnc Symbol;Acc:11389] 
ENSACAT00000001057 TGFB1 Transforming Growth Factor, Beta-Induced, 68Kda [Source:Hgnc 
Symbol;Acc:11771] 
ENSACAT00000001108 TGFB2 Transforming Growth Factor, Beta 2 [Source:Hgnc Symbol;Acc:11768] 
ENSACAT00000017101 TGFB3 Transforming Growth Factor, Beta 3 [Source:Hgnc Symbol;Acc:11769] 
ENSACAT00000025616 TGFBP3L Transforming Growth Factor, Beta Receptor Iii-Like [Source:Hgnc 
Symbol;Acc:44152] 
ENSACAT00000009230 TGFBR1 Transforming Growth Factor, Beta Receptor 1 [Source:Hgnc 
Symbol;Acc:11772] 
ENSACAT00000014316 TGFBR2 Transforming Growth Factor, Beta Receptor Ii (70/80Kda) 
[Source:Hgnc Symbol;Acc:11773] 
ENSACAT00000001424 TGFBR3 Transforming Growth Factor, Beta Receptor Iii [Source:Hgnc 
Symbol;Acc:11774] 
ENSACAT00000004260 TSC1 Tuberous Sclerosis 1 [Source:Hgnc Symbol;Acc:12362] 
ENSACAT00000008992 TSC2 Tuberous Sclerosis 2 [Source:Hgnc Symbol;Acc:12363] 
ENSACAT00000013230 PRKAB2 Protein Kinase Amp-Activated Non-Catalytic Subunit Beta 2 
[Source:Hgnc Symbol;Acc:Hgnc:9379] 
ENSACAT00000006834 PRKAA2 Protein Kinase Amp-Activated Catalytic Subunit Alpha 2 [Source:Hgnc 
Symbol;Acc:Hgnc:9377] 
ENSACAT00000002435 PRKAG2 Protein Kinase Amp-Activated Non-Catalytic Subunit Gamma 2 
[Source:Hgnc Symbol;Acc:Hgnc:9386] 
ENSACAT00000010286 PRKAA1 Protein Kinase Amp-Activated Catalytic Subunit Alpha 1 [Source:Hgnc 
Symbol;Acc:Hgnc:9376] 
ENSACAT00000012952 PRKAG3 Protein Kinase Amp-Activated Non-Catalytic Subunit Gamma 3 
[Source:Ncbi Gene;Acc:100564629] 
ENSACAT00000008189 PRKAG1 Protein Kinase Amp-Activated Non-Catalytic Subunit Gamma 1 
[Source:Hgnc Symbol;Acc:Hgnc:9385] 
ENSACAT00000003404 PRKAB1 Protein Kinase Amp-Activated Non-Catalytic Subunit Beta 1 
[Source:Hgnc Symbol;Acc:Hgnc:9378] 
ENSACAT00000000480 MTOR Mechanistic Target Of Rapamycin (Serine/Threonine Kinase) 
[Source:Hgnc Symbol;Acc:3942] 
ENSACAT00000015594 RPS6KA2 Ribosomal Protein S6 Kinase A2 [Source:Hgnc 
Symbol;Acc:Hgnc:10431] 
ENSACAT00000006193 RPS6KC1 Ribosomal Protein S6 Kinase C1 [Source:Hgnc 
Symbol;Acc:Hgnc:10439] 
ENSACAT00000008356 RPS6KB2 Ribosomal Protein S6 Kinase B2 [Source:Hgnc 
Symbol;Acc:Hgnc:10437] 
ENSACAT00000012470 STRADA Ste20-Related Kinase Adaptor Alpha [Source:Hgnc 
Symbol;Acc:Hgnc:30172] 
ENSACAT00000001329 STRADB Ste20-Related Kinase Adaptor Beta [Source:Hgnc 
Symbol;Acc:Hgnc:13205] 
ENSACAT00000005087 RAG1 Recombination Activating 1 [Source:Hgnc Symbol;Acc:Hgnc:9831] 
ENSACAT00000005084 RAG2 Recombination Activating 2 [Source:Hgnc Symbol;Acc:Hgnc:9832] 
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ENSACAT00000011317 BRAF B-Raf Proto-Oncogene, Serine/Threonine Kinase [Source:Hgnc 
Symbol;Acc:Hgnc:1097] 
ENSACAT00000011021 HIF1AN Hypoxia Inducible Factor 1 Subunit Alpha Inhibitor [Source:Hgnc 
Symbol;Acc:Hgnc:17113] 
ENSACAT00000005963 VEGFC Vascular Endothelial Growth Factor C [Source:Hgnc 
Symbol;Acc:Hgnc:12682] 
ENSACAT00000001649 VEGFA Vascular Endothelial Growth Factor A [Source:Hgnc 
Symbol;Acc:Hgnc:12680] 
ENSACAT00000012033 EIF4B Eukaryotic Translation Initiation Factor 4B [Source:Hgnc 
Symbol;Acc:Hgnc:3285] 
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Table 2.2 A priori growth genes in the growth hormone/insulin-like factor 1 pathway. Gene IDs 
ending in “.1” and “.2” reflect the 201 splice variant and 202 splice variant of the gene, 
respectively. 
Ensembl transcript ID Gene ID Ensembl description 
ENSACAT00000010700 GHR Growth Hormone Receptor [Source:Hgnc Symbol;Acc:4263] 
ENSACAT00000006111 GHRRH Growth Hormone Releasing Hormone Receptor [Source:Hgnc 
Symbol;Acc:4266] 
ENSACAT00000016563 IGF1 Insulin-Like Growth Factor 1 (Somatomedin C) [Source:Hgnc 
Symbol;Acc:5464] 
ENSACAT00000008062 IGFBP1 Insulin-Like Growth Factor Binding Protein 1 [Source:Hgnc 
Symbol;Acc:5469] 
ENSACAT00000004558 IGFBP2 Insulin-Like Growth Factor Binding Protein 2, 36Kda [Source:Hgnc 
Symbol;Acc:5471] 
ENSACAT00000008083 IGFBP3 Insulin-Like Growth Factor Binding Protein 3 [Source:Hgnc 
Symbol;Acc:5472] 
ENSACAT00000016203 IGFBP4 Insulin-Like Growth Factor Binding Protein 4 [Source:Hgnc 
Symbol;Acc:5473] 
ENSACAT00000000083 IGFBP5 Insulin-Like Growth Factor Binding Protein 5 [Source:Hgnc 
Symbol;Acc:5474] 
ENSACAT00000029049 IGFBP6 Insulin-Like Growth Factor Binding Protein 6 [Source:Hgnc 
Symbol;Acc:5475] 
ENSACAT00000002051 IGFBP7 Insulin-Like Growth Factor Binding Protein 7 [Source:Hgnc 
Symbol;Acc:5476] 
ENSACAT00000029347 IGF1R.1 Insulin-Like Growth Factor 1 Receptor [Source:Hgnc Symbol;Acc:5465] 
ENSACAT00000008235 IGF1R.2 Insulin-Like Growth Factor 1 Receptor [Source:Hgnc Symbol;Acc:5465] 
ENSACAT00000009701 IGF2 Insulin-Like Growth Factor 2 (Somatomedin A) [Source:Hgnc 
Symbol;Acc:5466] 
ENSACAT00000006271 IGF2BP1 Insulin-Like Growth Factor 2 Mrna Binding Protein 1 [Source:Hgnc 
Symbol;Acc:28866] 
ENSACAT00000008070 IGF2BP2 Insulin-Like Growth Factor 2 Mrna Binding Protein 2 [Source:Hgnc 
Symbol;Acc:28867] 
ENSACAT00000013612 IGF2BP3 Insulin-Like Growth Factor 2 Mrna Binding Protein 3 [Source:Hgnc 
Symbol;Acc:28868] 
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Table 2.3 A priori growth genes in the insulin-signaling pathway. Gene IDs ending in “.1” and 
“.2” reflect the 201 splice variant and 202 splice variant of the gene, respectively. 
Ensembl ID Gene Ensembl description 
ENSACAT00000011634 AKT1 Akt Serine/Threonine Kinase 1 [Source:Hgnc Symbol;Acc:Hgnc:391] 
ENSACAT00000002209 Cbl Cbl Proto-Oncogene [Source:Hgnc Symbol;Acc:Hgnc:1541] 
ENSACAT00000004315 CDKN1B Cyclin-Dependent Kinase Inhibitor 1B (P27, Kip1) [Source:Hgnc 
Symbol;Acc:1785] 
ENSACAT00000029358 EIF4EBP1 Eukaryotic Translation Initiation Factor 4E Binding Protein 1 
[Source:Hgnc Symbol;Acc:3288] 
ENSACAT00000014236 EIF4E Eukaryotic Translation Initiation Factor 4E [Source:Hgnc 
Symbol;Acc:3287] 
ENSACAT00000017135 GYS2 Glycogen Synthase 2 [Source:Hgnc Symbol;Acc:Hgnc:4707] 
ENSACAT00000004836 GYS1 Glycogen Synthase 1 [Source:Hgnc Symbol;Acc:Hgnc:4706] 
ENSACAT00000004723 ELK1 Ets Transcription Factor [Source:Hgnc Symbol;Acc:Hgnc:3321] 
ENSACAT00000009932 FASN Fatty Acid Synthase [Source:Hgnc Symbol;Acc:Hgnc:3594] 
ENSACAT00000013303 FBP1 Fructose-Bisphosphatase 1 [Source:Hgnc Symbol;Acc:Hgnc:3606] 
ENSACAT00000008015 FLOT2 Flotillin 2 [Source:Ncbi Gene;Acc:100563055] 
ENSACAT00000017291 FLOT1 Flotillin 1 [Source:Hgnc Symbol;Acc:Hgnc:3757] 
ENSACAT00000001070 G6PC2 Glucose-6-Phosphatase Catalytic Subunit 2 [Source:Hgnc 
Symbol;Acc:Hgnc:28906] 
ENSACAT00000007397 GNL3.1 G Protein Nucleolar 3 [Source:Hgnc Symbol;Acc:Hgnc:29931] 
ENSACAT00000026449 GNL3.2 G Protein Nucleolar 3 [Source:Hgnc Symbol;Acc:Hgnc:29931] 
ENSACAT00000006564 GRB2 Growth Factor Receptor-Bound Protein 2 [Source:Hgnc 
Symbol;Acc:4566] 
ENSACAT00000016466 RAPGEF2 Rap Guanine Nucleotide Exchange Factor 2 [Source:Hgnc 
Symbol;Acc:Hgnc:16854] 
ENSACAT00000013894 RAPGEF1 Rap Guanine Nucleotide Exchange Factor 1 [Source:Ncbi 
Gene;Acc:100558908] 
ENSACAT00000029738 GSK3B.1 Glycogen Synthase Kinase 3 Beta [Source:Hgnc 
Symbol;Acc:Hgnc:4617] 201 Splice Variant 
ENSACAT00000003712 GSK3B.2 Glycogen Synthase Kinase 3 Beta [Source:Hgnc 
Symbol;Acc:Hgnc:4617] 202 Splice Variant 
ENSACAT00000007957 HSL Hormone Sensitive Lipase 
ENSACAT00000003820 IRS1 Insulin Receptor Substrate 1 [Source:Hgnc Symbol;Acc:6125] 
ENSACAT00000012637 IRS4 Insulin Receptor Substrate 4 [Source:Hgnc Symbol;Acc:6128] 
ENSACAT00000000408 MAP2K2 Mitogen-Activated Protein Kinase Kinase 2 [Source:Hgnc 
Symbol;Acc:6842] 
ENSACAT00000001764 MAP2K3 Mitogen-Activated Protein Kinase Kinase 3 [Source:Hgnc 
Symbol;Acc:6843] 
ENSACAT00000017532 MAP2K4 Mitogen-Activated Protein Kinase Kinase 4 [Source:Hgnc 
Symbol;Acc:6844] 
ENSACAT00000010177 MAP2K5 Mitogen-Activated Protein Kinase Kinase 5 [Source:Hgnc 
Symbol;Acc:6845] 
ENSACAT00000030866 MAP2K6 Mitogen-Activated Protein Kinase Kinase 6 [Source:Hgnc 
Symbol;Acc:6846] 
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ENSACAT00000009956 MAP2K7 Mitogen-Activated Protein Kinase Kinase 7 [Source:Hgnc 
Symbol;Acc:6847] 
ENSACAT00000013773 MLST8 Mtor Associated Protein, Lst8 Homolog (S. Cerevisiae) [Source:Hgnc 
Symbol;Acc:24825] 
ENSACAT00000010374 MYC Myc Proto-Oncogene, Bhlh Transcription Factor [Source:Hgnc 
Symbol;Acc:Hgnc:7553] 
ENSACAT00000013790 NR3C1 Nuclear Receptor Subfamily 3, Group C, Member 1 (Glucocorticoid 
Receptor) [Source:Hgnc Symbol;Acc:7978] 
ENSACAT00000017591 PDE3A Phosphodiesterase 3A [Source:Hgnc Symbol;Acc:Hgnc:8778] 
ENSACAT00000003554 PDPK1 3-Phosphoinositide Dependent Protein Kinase-1 [Source:Hgnc 
Symbol;Acc:8816] 
ENSACAT00000016391 PCK1 Phosphoenolpyruvate Carboxykinase 1 [Source:Hgnc 
Symbol;Acc:Hgnc:8724] 
ENSACAT00000001275 PCK2 Phosphoenolpyruvate Carboxykinase 2, Mitochondrial [Source:Hgnc 
Symbol;Acc:Hgnc:8725] 
ENSACAT00000004827 PPARA Peroxisome Proliferator Activated Receptor Alpha [Source:Hgnc 
Symbol;Acc:Hgnc:9232] 
ENSACAT00000011918 PHKA2 Phosphorylase Kinase Regulatory Subunit Alpha 2 [Source:Hgnc 
Symbol;Acc:Hgnc:8926] 
ENSACAT00000014131 PHKB Phosphorylase Kinase Regulatory Subunit Beta [Source:Hgnc 
Symbol;Acc:Hgnc:8927] 
ENSACAT00000004979 PIK3CA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase, Catalytic Subunit Alpha 
[Source:Hgnc Symbol;Acc:8975] 
ENSACAT00000017770 PIK3R5.1 Phosphoinositide-3-Kinase, Regulatory Subunit 5 [Source:Hgnc 
Symbol;Acc:30035] 
ENSACAT00000029838 PIK3R5.2 Phosphoinositide-3-Kinase, Regulatory Subunit 5 [Source:Hgnc 
Symbol;Acc:30035] 
ENSACAT00000006498 PRKCH Protein Kinase C, Eta [Source:Hgnc Symbol;Acc:9403] 
ENSACAT00000015152 PTEN Phosphatase And Tensin Homolog [Source:Hgnc Symbol;Acc:9588] 
ENSACAT00000014006 PYG Glycogen Phosphorylase 
ENSACAT00000012973 RAC1 Rac Family Small Gtpase 1 [Source:Hgnc Symbol;Acc:Hgnc:9801] 
ENSACAT00000016135 RAC2 Rac Family Small Gtpase 2 [Source:Hgnc Symbol;Acc:Hgnc:9802] 
ENSACAT00000029270 RAF1.1 Raf-1 Proto-Oncogene, Serine/Threonine Kinase [Source:Hgnc 
Symbol;Acc:Hgnc:9829] 
ENSACAT00000013316 RAF1.2 Raf-1 Proto-Oncogene, Serine/Threonine Kinase [Source:Hgnc 
Symbol;Acc:Hgnc:9829] 
ENSACAT00000004483 RASD1 Ras, Dexamethasone-Induced 1 [Source:Hgnc Symbol;Acc:15828] 
ENSACAT00000002273 Rheb Ras Homolog, Mtorc1 Binding [Source:Hgnc Symbol;Acc:Hgnc:10011] 
ENSACAT00000014310 RHO Rhodopsin [Source:Hgnc Symbol;Acc:10012] 
ENSACAT00000010084 RICTOR Rptor Independent Companion Of Mtor, Complex 2 [Source:Hgnc 
Symbol;Acc:28611] 
ENSACAT00000013049 RPS6KB1 Ribosomal Protein S6 Kinase B1 [Source:Hgnc 
Symbol;Acc:Hgnc:10436] 
ENSACAT00000016838 RPS6KL1 Ribosomal Protein S6 Kinase-Like 1 [Source:Hgnc Symbol;Acc:20222] 
ENSACAT00000015640 RPTOR Regulatory Associated Protein Of Mtor, Complex 1 [Source:Hgnc 
Symbol;Acc:30287] 
ENSACAT00000014553 SHBG Sex Hormone-Binding Globulin [Source:Hgnc Symbol;Acc:10839] 
ENSACAT00000015879 SHC1 Shc Adaptor Protein 1 [Source:Hgnc Symbol;Acc:Hgnc:10840] 
ENSACAT00000012679 SHC2 Shc Adaptor Protein 2 [Source:Ncbi Gene;Acc:100553545] 
ENSACAT00000005997 SHC4 Shc Adaptor Protein 4 [Source:Hgnc Symbol;Acc:Hgnc:16743] 
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ENSACAT00000014599 SOCS1 Suppressor Of Cytokine Signaling 1 [Source:Hgnc 
Symbol;Acc:Hgnc:19383] 
ENSACAT00000012617 SOCS2 Suppressor Of Cytokine Signaling 2 [Source:Hgnc 
Symbol;Acc:Hgnc:19382] 
ENSACAT00000016743 SOCS3 Suppressor Of Cytokine Signaling 3 [Source:Hgnc 
Symbol;Acc:Hgnc:19391] 
ENSACAT00000016330 SOCS4 Suppressor Of Cytokine Signaling 4 [Source:Hgnc 
Symbol;Acc:Hgnc:19392] 
ENSACAT00000004217 SOCS5 Suppressor Of Cytokine Signaling 5 [Source:Hgnc 
Symbol;Acc:Hgnc:16852] 
ENSACAT00000011543 SOCS6 Suppressor Of Cytokine Signaling 6 [Source:Hgnc 
Symbol;Acc:Hgnc:16833] 
ENSACAT00000007427 SOCS7 Suppressor Of Cytokine Signaling 7 [Source:Hgnc 
Symbol;Acc:Hgnc:29846] 
ENSACAT00000006394 SOS1 Sos Ras/Rac Guanine Nucleotide Exchange Factor 1 [Source:Hgnc 
Symbol;Acc:Hgnc:11187] 
ENSACAT00000001643 SOS2 Sos Ras/Rho Guanine Nucleotide Exchange Factor 2 [Source:Hgnc 
Symbol;Acc:Hgnc:11188] 
ENSACAT00000006298 STAT1 Signal Transducer And Activator Of Transcription 1, 91Kda 
[Source:Hgnc Symbol;Acc:11362] 
ENSACAT00000025425 STAT2 Signal Transducer And Activator Of Transcription 2, 113Kda 
[Source:Hgnc Symbol;Acc:11363] 
ENSACAT00000018021 STAT3 Signal Transducer And Activator Of Transcription 3 (Acute-Phase 
Response Factor) [Source:Hgnc Symbol;Acc:11364] 
ENSACAT00000009792 STAT6 Signal Transducer And Activator Of Transcription 6, Interleukin-4 
Induced [Source:Hgnc Symbol;Acc:11368] 
ENSACAT00000014051 STK11 Serine/Threonine Kinase 11 [Source:Hgnc Symbol;Acc:11389] 
ENSACAT00000001057 TGFB1 Transforming Growth Factor, Beta-Induced, 68Kda [Source:Hgnc 
Symbol;Acc:11771] 
ENSACAT00000001108 TGFB2 Transforming Growth Factor, Beta 2 [Source:Hgnc Symbol;Acc:11768] 
ENSACAT00000017101 TGFB3 Transforming Growth Factor, Beta 3 [Source:Hgnc Symbol;Acc:11769] 
ENSACAT00000025616 TGFBP3L Transforming Growth Factor, Beta Receptor Iii-Like [Source:Hgnc 
Symbol;Acc:44152] 
ENSACAT00000009230 TGFBR1 Transforming Growth Factor, Beta Receptor 1 [Source:Hgnc 
Symbol;Acc:11772] 
ENSACAT00000014316 TGFBR2 Transforming Growth Factor, Beta Receptor Ii (70/80Kda) [Source:Hgnc 
Symbol;Acc:11773] 
ENSACAT00000001424 TGFBR3 Transforming Growth Factor, Beta Receptor Iii [Source:Hgnc 
Symbol;Acc:11774] 
ENSACAT00000004260 TSC1 Tuberous Sclerosis 1 [Source:Hgnc Symbol;Acc:12362] 
ENSACAT00000008992 TSC2 Tuberous Sclerosis 2 [Source:Hgnc Symbol;Acc:12363] 
ENSACAT00000013230 PRKAB2 Protein Kinase Amp-Activated Non-Catalytic Subunit Beta 2 
[Source:Hgnc Symbol;Acc:Hgnc:9379] 
ENSACAT00000006834 PRKAA2 Protein Kinase Amp-Activated Catalytic Subunit Alpha 2 [Source:Hgnc 
Symbol;Acc:Hgnc:9377] 
ENSACAT00000002435 PRKAG2 Protein Kinase Amp-Activated Non-Catalytic Subunit Gamma 2 
[Source:Hgnc Symbol;Acc:Hgnc:9386] 
ENSACAT00000010286 PRKAA1 Protein Kinase Amp-Activated Catalytic Subunit Alpha 1 [Source:Hgnc 
Symbol;Acc:Hgnc:9376] 
ENSACAT00000012952 PRKAG3 Protein Kinase Amp-Activated Non-Catalytic Subunit Gamma 3 
[Source:Ncbi Gene;Acc:100564629] 
ENSACAT00000008189 PRKAG1 Protein Kinase Amp-Activated Non-Catalytic Subunit Gamma 1 
[Source:Hgnc Symbol;Acc:Hgnc:9385] 
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ENSACAT00000003404 PRKAB1 Protein Kinase Amp-Activated Non-Catalytic Subunit Beta 1 
[Source:Hgnc Symbol;Acc:Hgnc:9378] 
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Table 2.4 A priori growth genes in mechanistic target of rapamycin pathway. Gene IDs ending 
in “.1” and “.2” reflect the 201 splice variant and 202 splice variant of the gene, respectively. 
Ensembl ID Gene ID Ensembl description 
ENSACAT00000011634 AKT1 Akt Serine/Threonine Kinase 1 [Source:Hgnc Symbol;Acc:Hgnc:391] 
ENSACAT00000016563 IGF1 Insulin-Like Growth Factor 1 (Somatomedin C) [Source:Hgnc 
Symbol;Acc:5464] 
ENSACAT00000003820 IRS1 Insulin Receptor Substrate 1 [Source:Hgnc Symbol;Acc:6125] 
ENSACAT00000000480 MTOR Mechanistic Target Of Rapamycin (Serine/Threonine Kinase) 
[Source:Hgnc Symbol;Acc:3942] 
ENSACAT00000004979 PIK3CA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase, Catalytic Subunit 
Alpha [Source:Hgnc Symbol;Acc:8975] 
ENSACAT00000017770 PIK3R5.1 Phosphoinositide-3-Kinase, Regulatory Subunit 5 [Source:Hgnc 
Symbol;Acc:30035] 
ENSACAT00000029838 PIK3R5.2 Phosphoinositide-3-Kinase, Regulatory Subunit 5 [Source:Hgnc 
Symbol;Acc:30035] 
ENSACAT00000015152 PTEN Phosphatase And Tensin Homolog [Source:Hgnc Symbol;Acc:9588] 
ENSACAT00000010084 RICTOR Rptor Independent Companion Of Mtor, Complex 2 [Source:Hgnc 
Symbol;Acc:28611] 
ENSACAT00000015640 RPTOR Regulatory Associated Protein Of Mtor, Complex 1 [Source:Hgnc 
Symbol;Acc:30287] 
ENSACAT00000004260 TSC1 Tuberous Sclerosis 1 [Source:Hgnc Symbol;Acc:12362] 
ENSACAT00000008992 TSC2 Tuberous Sclerosis 2 [Source:Hgnc Symbol;Acc:12363] 
ENSACAT00000015594 RPS6KA2 Ribosomal Protein S6 Kinase A2 [Source:Hgnc 
Symbol;Acc:Hgnc:10431] 
ENSACAT00000006193 RPS6KC1 Ribosomal Protein S6 Kinase C1 [Source:Hgnc 
Symbol;Acc:Hgnc:10439] 
ENSACAT00000008356 RPS6KB2 Ribosomal Protein S6 Kinase B2 [Source:Hgnc 
Symbol;Acc:Hgnc:10437] 
ENSACAT00000013230 PRKAB2 Protein Kinase Amp-Activated Non-Catalytic Subunit Beta 2 
[Source:Hgnc Symbol;Acc:Hgnc:9379] 
ENSACAT00000006834 PRKAA2 Protein Kinase Amp-Activated Catalytic Subunit Alpha 2 [Source:Hgnc 
Symbol;Acc:Hgnc:9377] 
ENSACAT00000002435 PRKAG2 Protein Kinase Amp-Activated Non-Catalytic Subunit Gamma 2 
[Source:Hgnc Symbol;Acc:Hgnc:9386] 
ENSACAT00000010286 PRKAA1 Protein Kinase Amp-Activated Catalytic Subunit Alpha 1 [Source:Hgnc 
Symbol;Acc:Hgnc:9376] 
ENSACAT00000012952 PRKAG3 Protein Kinase Amp-Activated Non-Catalytic Subunit Gamma 3 
[Source:Ncbi Gene;Acc:100564629] 
ENSACAT00000008189 PRKAG1 Protein Kinase Amp-Activated Non-Catalytic Subunit Gamma 1 
[Source:Hgnc Symbol;Acc:Hgnc:9385] 
ENSACAT00000003404 PRKAB1 Protein Kinase Amp-Activated Non-Catalytic Subunit Beta 1 
[Source:Hgnc Symbol;Acc:Hgnc:9378] 
ENSACAT00000014051 STK11 Serine/Threonine Kinase 11 [Source:Hgnc Symbol;Acc:Hgnc:11389] 
ENSACAT00000012470 STRADA Ste20-Related Kinase Adaptor Alpha [Source:Hgnc 
Symbol;Acc:Hgnc:30172] 
ENSACAT00000001329 STRADB Ste20-Related Kinase Adaptor Beta [Source:Hgnc 
Symbol;Acc:Hgnc:13205] 
ENSACAT00000005087 RAG1 Recombination Activating 1 [Source:Hgnc Symbol;Acc:Hgnc:9831] 
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ENSACAT00000005084 RAG2 Recombination Activating 2 [Source:Hgnc Symbol;Acc:Hgnc:9832] 
ENSACAT00000011317 BRAF B-Raf Proto-Oncogene, Serine/Threonine Kinase [Source:Hgnc 
Symbol;Acc:Hgnc:1097] 
ENSACAT00000011021 HIF1AN Hypoxia Inducible Factor 1 Subunit Alpha Inhibitor [Source:Hgnc 
Symbol;Acc:Hgnc:17113] 
ENSACAT00000005963 VEGFC Vascular Endothelial Growth Factor C [Source:Hgnc 
Symbol;Acc:Hgnc:12682] 
ENSACAT00000001649 VEGFA Vascular Endothelial Growth Factor A [Source:Hgnc 
Symbol;Acc:Hgnc:12680] 
ENSACAT00000012033 EIF4B Eukaryotic Translation Initiation Factor 4B [Source:Hgnc 
Symbol;Acc:Hgnc:3285] 
ENSACAT00000029358 EIF4EBP1 Eukaryotic Translation Initiation Factor 4E Binding Protein 1 
[Source:Hgnc Symbol;Acc:Hgnc:3288] 
ENSACAT00000006498 PRKCH Protein Kinase C, Eta [Source:Hgnc Symbol;Acc:9403] 
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Table 2.5 A priori-selected growth genes that exhibit sex-biased expression in the liver at one, 
four, eight, and twelve months of age. Negative log2 fold change (log2FC) indicates male-biased 
expression while positive indicates female-biased expression. Bold font indicates genes that 
experienced sex-biased expression across multiple age points. Within each age group, genes are 
sorted from most male-biased to most female-biased. 
Age Sex-bias Gene log2FC log2CPM 
4 months Male Insulin-like growth factor 1 (IGF1) -3.26609 5.068586 
  MTOR Associated Protein, LST8 Homolog (MLST8) -1.44021 2.567336 
  Insulin-like growth factor binding protein 5 (IGFBP5) -1.32059 3.071516 
  Insulin-like growth factor 2 (IGF2) -1.09368 7.1934 
 Female TSC complex subunit 2 (TSC2) 0.582462 4.076259 
  Insulin receptor substrate 1 (IRS1) 1.605095 4.679922 
  SHC adaptor protein 4 (SHC4) 2.639907 1.325526 
  Transforming growth factor beta 1 (TGFB1) 2.723285 6.311321 
8 months Male Insulin-like growth factor 1 (IGF1) -4.06143 5.068586 
  SHC adaptor protein 4 (SHC4) -3.41342 1.325526 
  Insulin-like growth factor binding protein 5 (IGFBP5) -2.49348 3.071516 
  Insulin-like growth factor 2 (IGF2) -2.11091 7.1934 
  Insulin-like growth factor binding protein 2 (IGFBP2) -1.73827 3.948268 
  Insulin-like growth factor binding protein 4 (IGFBP4) -1.47126 5.304117 
  MTOR Associated Protein, LST8 Homolog (MLST8) -1.32475 2.567336 
  Eukaryotic translation initiation factor 4E binding protein 1 
(EIF4EBP1) 
-1.0943 6.694943 
  Insulin-like growth factor 2 mRNA binding protein 2 
(IGF2BP2) 
-0.80176 3.199163 
  Transforming growth factor beta receptor 2 (TGFBR2) -0.56924 5.489862 
  Flotillin 1 (FLOT1) -0.55335 6.685024 
  SOS Ras/Rac guanine nucleotide exchange factor 1 (SOS1) -0.50361 4.844445 
 Female Insulin-like growth factor 2 mRNA binding protein 3 
(IGF2BP3) 
0.560268 6.098526 
  Signal transducer and activator of transcription 3 (STAT3) 0.641014 5.483781 
  3-phosphoinositide dependent protein kinase 1 (PDPK1) 0.703481 5.291527 
  Phosphorylase kinase regulatory subunit alpha 2 (PHKA2) 0.825086 5.702679 
  Transforming growth factor beta 1 (TGFB1) 3.530401 6.311321 
12 months Male Insulin-like growth factor 1 (IGF1) -3.81765 5.068586 
  Insulin-like growth factor 2 (IGF2) -1.79678 7.1934 
  Insulin-like growth factor binding protein 4 (IGFBP4) -1.64652 5.304117 
  Insulin-like growth factor binding protein 2 (IGFBP2) -1.30289 3.948268 
  Glycogen synthase 2 (GYS2) -1.23066 4.886695 
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  Eukaryotic translation initiation factor 4E binding protein 1 
(EIF4EBP1) 
-1.22552 6.694943 
  Transforming growth factor beta 2 (TGFB2) -1.11422 2.970851 
  SHC adaptor protein 2 (SHC2) -1.02022 2.377493 
  Peroxisome proliferator activated receptor alpha (PPARA) -0.92378 4.404665 
  Vascular endothelial growth factor C (VEGFC) -0.77444 3.577911 
  Fructose-bisphosphatase 1 (FBP1) -0.72086 7.541905 
  Ribosomal protein S6 kinase C1 (RPS6KC1) -0.66652 5.81934 
  Glycogen phosphorylase (PYG) -0.6587 6.118753 
  Insulin-like growth factor 2 mRNA binding protein 2 
(IGF2BP2) 
-0.57099 3.199163 
  Mitogen-activated protein kinase kinase 3 (MAP2K3) -0.5619 5.286363 
  STE20-related kinase adaptor alpha (STRADA) -0.50406 4.171097 
  AKT serine/threonine kinase 1 (AKT1) -0.37438 7.162062 
 Female Insulin-like growth factor 2 mRNA binding protein 3 
(IGF2BP3) 
0.537954 6.098526 
  Protein kinase AMP-activated non-catalytic subunit beta 1 
(PRKAB1) 
0.807365 2.107514
4 
  Protein inhibitor of activated STAT 3 (STAT3) 0.886875 5.483781 
  Protein kinase AMP-activated non-catalytic subunit beta 2 
(PRKAB2) 
0.902312 5.004255 
  Glycogen synthase 1 (GYS1) 1.05015 6.797076 
  Fatty acid synthase (FASN) 2.947725 8.495907 
  Sex hormone-binding globulin (SHBG) 3.703496 3.502142 
  Transforming growth factor beta 1 (TGFB1) 3.706043 6.311321 
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Table 2.6 A priori-selected growth genes that exhibit sex-biased expression in femoral muscle at 
ages one, four, eight, and twelve months. Negative log2 fold change (log2FC) indicates male-
biased expression while positive indicates female-biased. Bold font indicates genes that 
experienced sex-biased expression across multiple ages. Within each age group, genes are sorted 
from most male-biased to most female-biased. 
Age Sex-bias Gene name log2FC log2CPM 
4 months Male Phosphoenolpyruvate carboxykinase 1 (PCK1) -1.40236 4.456375 
 Female Protein kinase AMP-activated non-catalytic subunit gamma 
3 (PRKAG3) 
0.737703 5.866955 
  Transforming growth factor beta receptor 3 (TGFBR3) 1.267989 4.075512 
  Cyclin dependent kinase inhibitor 1B (CDKN1B) 2.601503 7.172727 
8 months Male Suppressor of cytokine signaling 2 (SOCS2) -2.95466 2.762381 
  Insulin-like growth factor 1 (IGF1) -2.06985 5.068586 
  Insulin-like growth factor binding protein 2 (IGFBP2) -1.45219 3.948268 
 Female TSC complex subunit 2 (TSC2) 0.72961 4.076259 
  Protein kinase AMP-activated non-catalytic subunit gamma 
3 (PRKAG3) 
0.762862 5.866955 
  Protein kinase AMP-activated non-catalytic subunit beta 1 
(PRKAB1) 
0.834485 2.107514
4 
  Ribosomal protein S6 kinase B2 (RPS6KB2) 0.92198 2.720488 
  Transforming growth factor beta receptor 3 like (TGFBP3L) 0.995106 2.685145 
 
 Eukaryotic translation initiation factor 4E binding protein 1 
(EIF4EBP1) 
1.194363 6.694943 
12 months Male Cyclin dependent kinase inhibitor 1B (CDKN1B) -2.7931 7.172727 
  Eukaryotic translation initiation factor 4E binding protein 1 
(EIF4EBP1) 
-1.86076 6.694943 
  Insulin receptor substrate 4 (IRS4) -1.14339 4.88699 
  SOS Ras/Rac guanine nucleotide exchange factor 1 (SOS1) -0.69663 4.844445 
  Ribosomal protein S6 kinase B1 (RPS6KB1) -0.57022 3.665018 
 Female Eukaryotic translation initiation factor 4E (EIF4E) 0.458095 6.099981 
  Mitogen-activated protein kinase kinase 6 (MAP2K6) 0.486653 5.867802 
  Phosphoenolpyruvate carboxykinase 2, mitochondrial (PCK2) 0.662378 9.479602 
  Phosphodiesterase 3A (PDE3A) 1.050874 2.750514 
  Transforming growth factor beta 2 (TGFB2) 1.072561 2.970851 
  Insulin-like growth factor binding protein 4 (IGFBP4) 1.082546 5.304117 
  Insulin-like growth factor binding protein 7 (IGFBP7) 1.251951 3.201967 
  Glucose-6-phosphatase catalytic subunit 2 (G6PC2) 1.95452 0.695295 
  Sex hormone binding globulin (SHBG) 4.853266 3.502142 
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Table 2.7 The results of general linear models testing for sex, age, and tissue effects on mean 
expression level of the growth hormone/insulin-like growth factor (GH/IGF), insulin, and 
mechanistic target of rapamycin (mTOR) growth networks within liver, femoral muscle, and 
brain of brown anoles. We performed three tests and utilized a Bonferroni-corrected alpha level 
of 0.01667 to assess significance. Factors with significant p-values are bolded. 
Growth Network Factor Degrees of freedom F-value P-value 
GH-IGF1 Sex 1,72 1.709022563 0.191310998  
Age 3,72 1.378532682 0.24762889  
Tissue 2,72 42.57839534 < 0.0001  
Sex:Age 3,72 0.369295381 0.775180239  
Sex:Tissue 2,72 1.135102212 0.321662986  
Age:Tissue 6,72 0.51634094 0.79632685  
Sex:Age:Tissue 6,72 0.141520743 0.990665279 
 Residuals 72   
Insulin Sex 1,72 0.060586276 0.805577558  
Age 3,72 1.243771517 0.292047657  
Tissue 2,72 40.09893007 < 0.0001  
Sex:Age 3,72 0.131025711 0.941666011  
Sex:Tissue 2,72 0.044832051 0.956158277  
Age:Tissue 6,72 1.272038271 0.266432665  
Sex:Age:Tissue 6,72 0.034718432 0.999825685 
 Residuals 72   
mTOR Sex 1,72 1.624251024 0.202591457  
Age 3,72 0.938977373 0.420849429  
Tissue 2,72 25.28729728 < 0.0001  
Sex:Age 3,72 0.458433299 0.711353383  
Sex:Tissue 2,72 1.004560267 0.366319662  
Age:Tissue 6,72 0.263583759 0.953856164  
Sex:Age:Tissue 6,72 0.131756156 0.992314701 
 Residuals 72   
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Table 2.8 The results of general linear models testing for sex and age effects on mean expression 
level of target growth genes within liver, femoral muscle, and brain of brown anoles. We 
performed 15 tests and utilized a Bonferroni-corrected alpha level of 0.0033 to assess 
significance. Significant p-values are bolded. 
Gene Factor Degrees of freedom F-value P-value 
IGF1 Sex 1,72 66.80991 < 0.0001 
 
Age 3,72 0.431348 0.731177 
 
Tissue 2,72 85.17288 < 0.0001 
 
Sex:Age 3,72 1.570839 0.20388 
 
Sex:Tissue 2,72 62.22524 < 0.0001 
 
Age:Tissue 6,72 0.800266 0.572909 
 
Sex:Age:Tissue 6,72 1.655884 0.144427 
 Residuals 72   
IGF2 Sex 1,72 33.24968 < 0.0001 
 
Age 3,72 6.04856 0.000988 
 
Tissue 2,72 112.1735 < 0.0001 
 
Sex:Age 3,72 2.605883 0.05827 
 
Sex:Tissue 2,72 33.11659 < 0.0001 
 
Age:Tissue 6,72 6.078545 < 0.0001 
 Sex:Age:Tissue 6,72 2.949206 0.01514 
 
Residuals 72 
  
GHR Sex 1,72 0.026388 0.87141 
 
Age 3,72 14.69438 < 0.0001 
 
Tissue 2,72 307.1242 < 0.0001 
 
Sex:Age 3,72 2.565761 0.061183 
 
Sex:Tissue 2,72 1.600401 0.208911 
 
Age:Tissue 6,72 4.893104 < 0.0001 
 Sex:Age:Tissue 6,72 0.97317 0.44969 
 
Residuals 72 
  
IGFBP1 Sex 1,72 0.581925 0.448051 
 
Age 3,72 0.349068 0.789923 
 
Tissue 2,72 87.48913 < 0.0001 
 
Sex:Age 3,72 0.989221 0.402837 
 
Sex:Tissue 2,72 0.290594 0.748692 
 
Age:Tissue 6,72 0.396578 0.878916 
 Sex:Age:Tissue 6,72 0.975052 0.448445 
 
Residuals 72 
  
IGFBP2 Sex 1,72 68.85054 < 0.0001 
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Age 3,72 5.561551 0.001727 
 
Tissue 2,72 347.0924 < 0.0001 
 
Sex:Age 3,72 1.303807 0.279835 
 
Sex:Tissue 2,72 58.23178 < 0.0001 
 
Age:Tissue 6,72 5.597962 < 0.0001 
 Sex:Age:Tissue 6,72 1.261543 0.285967 
 
Residuals 72 
  
IGFBP3 Sex 1,72 1.310838 0.256035 
 
Age 3,72 0.251323 0.860144 
 
Tissue 2,72 28.30902 < 0.0001 
 
Sex:Age 3,72 0.385727 0.7636 
 
Sex:Tissue 2,72 1.409482 0.250928 
 
Age:Tissue 6,72 0.321237 0.923852 
 Sex:Age:Tissue 6,72 0.351155 0.906999 
 
Residuals 72 
  
IGFBP4 Sex 1,72 56.97257 < 0.0001 
 
Age 3,72 9.670478 < 0.0001 
 
Tissue 2,72 261.5358 < 0.0001 
 
Sex:Age 3,72 4.284489 0.007708 
 
Sex:Tissue 2,72 59.02825 < 0.0001 
 
Age:Tissue 6,72 9.498694 < 0.0001 
 Sex:Age:Tissue 6,72 4.999205 0.000248 
 
Residuals 72 
  
IGFBP5 Sex 1,72 13.11801 0.000541 
 
Age 3,72 4.818883 0.004099 
 
Tissue 2,72 388.3431 < 0.0001 
 
Sex:Age 3,72 2.344726 0.080045 
 
Sex:Tissue 2,72 7.598672 0.001014 
 
Age:Tissue 6,72 5.944202 < 0.0001 
 Sex:Age:Tissue 6,72 2.313792 0.042419 
 
Residuals 72 
  
IGFBP6 Sex 1,72 0.109208 0.742008 
 
Age 3,72 0.149 0.93001 
 
Tissue 2,72 20.7183 < 0.0001 
 
Sex:Age 3,72 0.153907 0.92685 
 
Sex:Tissue 2,72 0.362619 0.697115 
 
Age:Tissue 6,72 0.46904 0.829084 
 Sex:Age:Tissue 6,72 1.188918 0.321994 
 
Residuals 72 
  
IGFBP7 Sex 1,72 0.085435 0.770903 
 
Age 3,72 0.533129 0.661027 
 
Tissue 2,72 157.0725 < 0.0001 
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Sex:Age 3,72 0.207693 0.89076 
 
Sex:Tissue 2,72 10.29629 0.000117 
 
Age:Tissue 6,72 1.29245 0.271666 
 Sex:Age:Tissue 6,72 1.845839 0.102194 
 
Residuals 72 
  
IGF1R.1 Sex 1,72 1.245963 0.268036 
 
Age 3,72 2.603406 0.058446 
 
Tissue 2,72 32.76004 < 0.0001 
 
Sex:Age 3,72 1.373364 0.25781 
 
Sex:Tissue 2,72 0.219316 0.803602 
 
Age:Tissue 6,72 2.076334 0.066525 
 Sex:Age:Tissue 6,72 0.507129 0.801027 
 
Residuals 72 
  
IGF1R.2 Sex 1,72 0.006295 0.936982 
 
Age 3,72 1.442279 0.237608 
 
Tissue 2,72 11.61282 < 0.0001 
 
Sex:Age 3,72 0.951515 0.420434 
 
Sex:Tissue 2,72 3.651515 0.03087 
 
Age:Tissue 6,72 1.622886 0.153231 
 Sex:Age:Tissue 6,72 1.2796 0.277539 
 
Residuals 72 
  
IRS1 Sex 1,72 0.086976 0.768906 
 
Age 3,72 1.102839 0.353672 
 
Tissue 2,72 439.6721 < 0.0001 
 
Sex:Age 3,72 0.861962 0.464897 
 
Sex:Tissue 2,72 0.670339 0.514698 
 
Age:Tissue 6,72 0.983989 0.442558 
 Sex:Age:Tissue 6,72 0.773228 0.593503 
 
Residuals 72 
  
IRS4 Sex 1,72 2.31104 0.132838 
 
Age 3,72 6.465274 0.000616 
 
Tissue 2,72 62.05655 < 0.0001 
 
Sex:Age 3,72 5.030416 0.003199 
 
Sex:Tissue 2,72 3.072526 0.052422 
 
Age:Tissue 6,72 5.383692 0.000122 
 Sex:Age:Tissue 6,72 3.684442 0.003009 
 
Residuals 72 
  
MTOR Sex 1,72 0.024247 0.876694 
 
Age 3,72 8.928516 < 0.0001 
 
Tissue 2,72 53.05153 < 0.0001 
 
Sex:Age 3,72 0.033843 0.991577 
 
Sex:Tissue 2,72 0.896263 0.412595 
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Age:Tissue 6,72 6.936055 < 0.0001 
 
Sex:Age:Tissue 6,72 1.800405 0.111091 
 Residuals 72   
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Figure 2.1 A flow chart of the growth hormone/insulin-like factor, insulin signaling, and 
mechanistic target of rapamycin growth regulatory signaling pathways interact to direct growth 
in vertebrates, specifically in the liver.
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Figure 2.2 Male and female brown anoles increase and diverge in number of growth genes that exhibit sex-biased expression in the 
(A) liver and (B) femoral muscle across ontogeny.  
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Figure 2.3 Male and female brown anoles express growth genes at similar levels across ontogeny within tissues. Data are the average 
expression, in counts per million (CPM), of all a priori selected growth genes plotted against age in the A) liver, B) femoral muscle, 
and C) brain. Data are expressed as means (symbols) with standard error bars (error bars shorter than the height of the symbol are not 
depicted).  
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Figure 2.4 Male and female brown anoles diverge in growth gene sex-biased gene expression in the liver and muscle across ontogeny. 
Data are the average expression, in counts per million (CPM), of a priori selected growth genes that exhibit sex-biased expression 
plotted against age in the A) liver and B) femoral muscle. We did not find sex-biased growth gene expression in the brain for either 
sex at any age point. Data are expressed as means (symbols) with standard error bars (error bars shorter than the height of the symbol 
are not depicted).  
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Figure 2.5 Expression of growth hormone receptor (GHR) increases in the liver and muscle for both male and female brown anoles 
across ontogeny. Data are the mean expression of growth hormone receptor, in counts per million (CPM), plotted against age in the 
liver, femoral muscle, and brain. Data are expressed as means (symbols) with standard error bars (error bars shorter than the height of 
the symbol are not depicted).
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Figure 2.6 Male and female brown anoles diverge in expression of insulin-like growth factor 1 (IGF1) and insulin-like growth factor 2 
(IGF2) in the liver across ontogeny. Data are the mean expression of IGF1 and IGF2, in counts per million (CPM), plotted against age 
in the liver, femoral muscle, and brain. Data are expressed as means (symbols) with standard error bars (error bars shorter than the 
height of the symbol are not depicted).
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Figure 2.7 Male and female brown anole expression of the insulin growth factor binding 
proteins varies across tissues and ontogeny. Data are the mean expression of the IGFBPs, in 
counts per million (CPM), in male and female brown anoles at one, four, eight, and twelve 
months in the liver, femoral muscle, and brain. Data are expressed as means (symbols) with 
standard error bars (error bars shorter than the height of the symbol are not depicted).
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Figure 2.8 Male and female brown anoles diverge in their expression of the insulin-like growth factor 1 receptor across tissues and 
ontogeny. Data are the mean expression of insulin-like growth factor 1 receptor, expressed as the IGF1R-201 and IGF1R-202 splice 
variants, in counts per million (CPM) plotted against age in the liver, femoral muscle, and brain. Data are expressed as means 
(symbols) with standard error bars (error bars shorter than the height of the symbol are not depicted).  
107 
 
 
 
 
 
Figure 2.9 Male and female brown anoles diverge in their expression of insulin receptor substrate 1 (IRS1) and insulin receptor 
substrate 4 (IRS4) across tissues and ontogeny. Data are the mean expression of IRS1 and IRS4, in counts per million (CPM), plotted 
against age in the liver, femoral muscle, and brain. Data are expressed as means (symbols) with standard error bars (error bars shorter 
than the height of the symbol are not depicted).  
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Figure 2.10 Male and female brown anoles express the mechanistic target of rapamycin (mTOR) at similar levels across tissues and 
ontogeny. Data are the mean expression of mTOR, in counts per million (CPM), plotted against age in the liver, femoral muscle, and 
brain. Data are expressed as means (symbols) with standard error bars (error bars shorter than the height of the symbol are not 
depicted).  
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Figure 2.11 Male and female brown anoles have similar levels of expression of all growth genes in the growth hormone/insulin-like 
growth factor 1 signaling network within tissues across ontogeny. Data are the average expression, in counts per million (CPM), of all 
growth genes in the network plotted against age. Data are expressed as mean expression of genes in the network (symbols) with 
standard error bars (error bars shorter than the height of the symbol are not depicted).  
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Figure 2.12 Male and female brown anoles have similar levels of expression of growth genes in the insulin-signaling network across 
tissues and ontogeny. Data are the average expression, in counts per million (CPM), of all growth genes in the insulin-signaling 
network plotted against age. Data are expressed as mean expression of genes in the network (symbols) with standard error bars (error 
bars shorter than the height of the symbol are not depicted).  
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Figure 2.13 Male and female brown anoles have similar levels of expression of growth genes in the mechanistic target of rapamycin 
network across tissues and ontogeny. Data are the average expression, in counts per million (CPM), of all growth genes in the 
mechanistic target of rapamycin network plotted against age. Data are expressed as mean expression of genes in the network 
(symbols) with standard error bars (error bars shorter than the height of the symbol are not depicted). 
